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Abstract 
Luman (CREB3, LZIP) is a basic leucine zipper transcription factor involved in 
regulation of the unfolded protein response (UPR), dendritic cell maturation, and cell migration. 
But despite reported expression in primary sensory neurons, little is known about its role in the 
nervous system. Luman mRNA from rat sensory neurons was amplified and its coding sequence 
was determined. The rat Luman cDNA contains a full-length open reading frame encoding 387 
amino acids, and the recombinant protein generated from this clone activated transcription from 
UPR elements. Quantitative RT-PCR revealed rat Luman transcripts in a variety of rat tissues 
with the highest levels in nervous system tissue. In situ hybridization confirmed the findings and 
demonstrated that the Luman mRNA hybridization signal localizes to neurons and satellite glial 
cells in dorsal root ganglia (DRG), the cytoplasm of hepatocytes in liver, and the hippocampal 
pyramidal cell layers in CA1 and CA3 and the granular cell layer of the dentate gyrus. Luman 
protein localizes with axonal endoplasmic reticulum (ER) components along the axon length 
within the sciatic nerve and is activated by sciatic nerve injury. Adult sensory axons also contain 
Luman mRNA which is translated within the axon and transported to the cell body via the 
importin-mediated retrograde transport system in response to nerve injury. Further, creation of an 
N-terminal, C-terminal dual fluorescence-tagged Luman adenoviral construct allowed 
visualization of the cleavage and retrograde translocation of the N-terminal portion of Luman to 
the nucleus in real time in vivo and in vitro. Neuronal or subcellular axonal knockdown of 
Luman significantly impaired the intrinsic ability of injury-conditioned, but not naïve, sensory 
neurons to extend the regeneration-associated elongating form of neurites. Sciatic nerve crush 
injury also induced activation of the UPR in axotomized DRGs, including genes linked to 
cholesterol biosynthesis. Knockdown of Luman decreased the activation of UPR and cholesterol 
biosynthesis, and axotomy-inducted increases in neurite outgrowth, which could be largely 
rescued with either mild UPR inducer treatment or cholesterol supplementation. Together these 
findings provide novel insights linking remote injury-associated axonal ER responses to the 
regenerative growth capacity of adult sensory neurons via axonal activation and synthesis of 
Luman and reveal a role for the UPR in regulation of axotomy-induced neurite outgrowth that is 
critically dependent on Luman.  
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1 Introduction 
1.1 Peripheral nerve regeneration 
The peripheral nervous system (PNS) serves to connect the central nervous system (CNS) 
to the rest of the body, relaying sensory and motor information between brain and spinal cord 
and the extremities. Unlike the CNS, which is protected by bones and a blood brain barrier, the 
PNS is more vulnerable to chemical and mechanical insults. Indeed, among trauma patients, 5.1 % 
have PNS injuries (Noble et al., 1998), compared to 1.8 % having spinal cord injuries (Hasler et 
al., 2011). 
After injury, the PNS is capable of regeneration. Although the earliest study about PNS 
regeneration dates back to second century A.D. (Terzis et al., 1997), it was not until 1776, that a 
British chemist and anatomist William Cumberland Cruikshank did an experiment revealing the 
physiological aspects of nerve regeneration. It was known that after the bilateral severance of the 
vagus nerves, animals died after a survival period of “many days” (Willis and Feindel, 1681, 
reprinted in 1966). Cruikshank found that unilateral cutting of the vagus nerve was not lethal, 
and if some time was given before cutting the other vagus nerve, survival time was increased. 
After examining the experimental animal, he found that “the divided nerves of the right side 
(first cut) were firmly united; having their extremities covered with a kind of callous substance; 
the regenerating nerve, like bone in the same situation, converting the whole of the surrounding 
extravasated blood into its own substance.” (Cruickshank, 1795). 
At that time, scientists did not know whether the regeneration was caused by the reunion 
of the two cut ends of the nerve, or through the outgrowth of new fibres from the end that 
attached to the cell body. In 1850, the British neurophysiologist Augustus Volney Waller 
observed the disorganization of the frog hypoglossal nerves after axotomy. He noted, “On the 
fifth day the tubes (nerve) appear more varicose than usual, and the medulla (axon) more 
irregular. About the tenth day the medulla forms disorganized, fusiform masses at intervals, and 
where the white substance of Schwann cannot be detected… After twelve or fifteen days many 
of the single tubules have ceased to be visible, their granular medulla having been removed by 
absorption. The branches contain masses of amorphous medulla.” (Waller, 1850). This 
phenomenon, which is now known as Wallerian degeneration, suggested that the regeneration 
2 
 
was due to outgrowth but not reunion. But with increasing experimental evidence supporting 
reunion at that time, even Waller himself had accepted the reunion theory (Waller, 1861; Ochs, 
1977). 
The outgrowth and reunion debate, which lasted throughout the last half of the nineteenth 
century, was ended by a Spanish pathologist, histologist, and neuroscientist Santiago Ramón y 
Cajal. He improved a silver staining technique created by the Italian physician and scientist 
Camillo Golgi. This improved staining method, which is called Cajal’s stain, is still in use today. 
With the developed histological and microscopy techniques, Cajal confirmed Waller’s 
observation. “When one interrupts the continuity of a nerve by the scalpel or destructive agents, 
the peripheral stump degenerates rapidly, but all its constituent factors do not disappear. By a 
process of progressive liquefaction and absorption, the axon, myelin, and a part of the organs that 
are close to Schwann’s cell are destroyed.” He also found that after the severance of a nerve, 
“from the third day on, and sometimes before, the various collateral and terminal branches that 
issue from the fibres of the central stump have grown so much that they abandon the chambers 
formed by the membrane of Schwann and penetrate into the scar.” (Ramón y Cajal and May, 
1928, reprinted in 1959). Cajal’s work established the “neuron doctrine” that the nervous system 
is made up of individual cells with distinct structure, function and developmental properties. 
Within this, his work on repair of the nervous system led to the broad acceptance that injured 
axons grow in order to reconnect to target (outgrowth theory) as opposed to reuniting with the 
distal severed end of the nerve (reunion debate). 
Our understanding of PNS regeneration has since been significantly elucidated. We now 
know that for regeneration to occur, Wallerian degeneration and the associated influx of 
macrophages into both the distal nerve stump and the axotomized cell body are necessary (Lu 
and Richardson, 1991; Niemi et al., 2013), the axon must have intrinsic growth ability, and the 
growth environment must be permissive. Unfortunately, despite over 200 years research about 
PNS regeneration, functional recovery after PNS injury is still disappointing (Johnson et al., 
2005). Studying the cellular and molecular mechanisms behind PNS regeneration will not only 
help us understand the nature of this biological event, but also develop better approaches to treat 
PNS injuries. 
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1.1.1 Regeneration in PNS and CNS 
Unlike the PNS, the CNS has very limited regeneration ability. Scientists once believed 
that the CNS neurons had lost their intrinsic regeneration ability after development is completed. 
Cajal stated: “Pathologists consider it an unimpeachable dogma that there is no regeneration of 
the central paths… A vast series of anatomico-pathological experiments in animals, and an 
enormous number of clinical cases that have been methodically followed by autopsy, serve as a 
foundation for this doctrine, which is universally accepted to-day”. He believed that “the general 
attitude is to attribute the regenerative inefficiency of the centres to the absence of cells of 
Schwann” (Ramón y Cajal and May, 1928, reprinted in 1959). But this doctrine was challenged 
by the discovery that injured CNS neurons could regrow into peripheral nerve grafts containing 
Schwann cells (Richardson et al., 1980). Further, with respect to adult sensory neurons, the 
growth of the central axon of primary sensory neurons into a peripheral nerve graft occurs only if 
its peripheral axon had also been injured (Richardson and Issa, 1984), suggesting that both the 
environment and the neuron must be in a growth permissive state if axonal regeneration is to 
occur in the CNS. 
Research into the nonpermissive nature of the CNS environment for axon regrowth led to 
the identification of several intrinsic factors that inhibit growth in the CNS (McKerracher et al., 
1994; Filbin, 2003; Nash et al., 2009) being identified. However, recent studies showed that 
deletion or blockage of these intrinsic inhibitor factors did not achieve expected CNS axon 
regeneration in vivo, suggesting that the intrinsic growth ability is different between the PNS and 
CNS. For example, following injury, many CNS neurons fail to induce the expression of the 
growth-promoting genes which are highly up-regulated in injured PNS neurons (Huebner and 
Strittmatter, 2009), with proximity of the injury to the cell body perhaps impacting the response 
in the CNS (Richardson et al., 1984). The CNS axons also have a lower content of translational 
machinery than do the PNS axons (Verma et al., 2005), which results in less local protein 
synthesis that plays an important role in PNS regeneration (Gumy et al., 2010). 
1.1.2 Permissive growth environment 
Oligodendrocyte-derived myelin in the CNS and Schwann cell-derived myelin in the 
PNS are both nonpermissive to growth as they contain inhibitory molecules (McKerracher et al., 
1994; David et al., 1995). But the differential expression of laminin in the adult PNS versus CNS 
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(David et al., 1995) coupled with the more rapid clearance of myelin debris in the PNS (Vargas 
and Barres, 2007) are likely to be factors that contribute to the more permissive growth 
environment for the PNS axon. A positive impact on growth has also been linked to the 
availability of injury-associated cytokines [reviewed in (Zigmond, 2012)] and growth factors 
[reviewed in (Boyd and Gordon, 2003)], and activation of their associated signalling pathways. 
1.1.2.1 Physical barrier 
After CNS injury, the activation of astrocytes and recruitment of microglia lead to the 
formation of the glial scar (Cregg et al., 2014), which isolates the injury site and minimizes the 
area of inflammation, but also becomes a physical barrier for axonal outgrowth. However, in the 
PNS there is no glial scar formed, and Wallerian degeneration is highly effective in removing 
myelin debris distal to the site of axon injury within 2 weeks. In contrast Wallerian degeneration 
lasts from months to years in the CNS (Vargas and Barres, 2007). The delayed degeneration in 
the CNS contributes to the formation of glial scar in human spinal cord (Buss et al., 2004). Not 
only does the glial scar form a physical barrier, it also contains inhibitory molecules that hinder 
axon growth (Silver and Miller, 2004). The value of rapid Wallerian degeneration in PNS 
regeneration has been demonstrated by the Wlds mouse. This mouse has delayed Wallerian 
degeneration (Lunn et al., 1989), which shows impaired regeneration because of the persistence 
of distal axons (Bisby and Chen, 1990). It was later found out that the Wlds phenotype is due to 
the expression of a chimeric gene that contains the N-terminal 70 amino acids of ubiquitination 
factor E4B and the nicotinamide mononucleotide adenylyltransferase (Mack et al., 2001).  
1.1.2.2 Molecular barrier 
The main inhibitory molecules in the glial scar are chondroitin sulfate proteoglycans, a 
family of extracellular matrix molecules characterized by a protein core with glycosaminoglycan 
side chains (Morgenstern et al., 2002). Treatment with chondroitinase ABC, an enzyme that 
cleaved the side chains from the core protein, promotes functional recovery after spinal cord 
injury (Bradbury et al., 2002). 
Another major class of regeneration inhibitors is the myelin-associated inhibitors which 
are mainly found in the CNS but not in the PNS. One of the best characterized myelin-associated 
inhibitors is Nogo (GrandPre et al., 2000). Nogo inhibits neurite outgrowth in vitro (Prinjha et al., 
2000), and restricts axonal sprouting in vivo (Kim et al., 2003b). Forced expression of Nogo in 
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Schwann cells, which do not normally express it, delays axonal re-extension in PNS injury (Kim 
et al., 2003a). Genetic deletion of Nogo improves regeneration after spinal cord injury (Simonen 
et al., 2003). Antibodies that neutralize Nogo also promote axonal regeneration and functional 
recovery in CNS injuries (Wiessner et al., 2003; Seymour et al., 2005), and one such antibody 
has reached clinical trial (Zorner and Schwab, 2010). 
On the contrary, studies showed that elimination of Nogo is not sufficient to induce 
extensive axon regeneration (Zheng et al., 2003), and genetic deletion of other myelin-associated 
inhibitors fails to increase axon regeneration (Lee et al., 2010), which suggests either the 
existence of other inhibitory factors or that the removal of the inhibitory environment alone is 
insufficient to support regrowth of injured axons. For example, knockdown of retinoblastoma 
protein, a tumor suppressor protein, increases axonal regeneration and functional recovery 
(Christie et al., 2014). In addition, increasing the intrinsic growth ability of injured DRG by 
axotomy to the peripheral branch before (Neumann and Woolf, 1999), at the same time as 
(Neumann et al., 2005), or after (Ylera et al., 2009) axotomy to the central branch, greatly 
enhances the regeneration of the central branch. This indicates that the failure of axonal 
regeneration in the CNS is not solely due to the existence of inhibitory environments, but also 
due to the lack of intrinsic growth ability. 
1.1.3 Intrinsic growth ability 
1.1.3.1 Up-regulation of regeneration-associated genes 
Injury to PNS neurons leads to the up-regulation of several regeneration-associated genes 
(RAGs), which plays a direct role in nerve regeneration. These include transcription factors such 
as activating transcription factor 3 (ATF3) (Tsujino et al., 2000), c-Jun (Raivich et al., 2004), 
signal transducer and activator of transcription 3 (STAT3) (Schwaiger et al., 2000), and SRY-
box containing gene 11 (Sox11) (Jankowski et al., 2009); and growth associated proteins such as 
growth associated protein 43 (GAP43) and CAP23 (Bomze et al., 2001). 
These RAGs are of importance in regulating nerve regeneration. Forced expression of 
GAP43 promotes neurite outgrowth (Seijffers et al., 2007); Sox11(Jankowski et al., 2009) and c-
Jun (Ruff et al., 2012) are required for axonal regeneration; and deletion of STAT3 in DRG 
neurons impairs the regeneration of peripheral DRG branches (Bareyre et al., 2011). However, in 
injured CNS neurons, the up-regulation of RAGs requires injury proximal to the cell body 
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(Doster et al., 1991) and does not happen or only transiently happens if axons are injured at 
greater distances from the cell bodies (Fernandes et al., 1999; Liu et al., 2011) the latter 
correlating with reduced regenerative propensity for these axons (Richardson and Verge, 1986). 
Not only is the synthesis of RAGs required for regeneration, but where the protein 
synthesis takes place is also important. For example, only axonally synthesized GAP43, but not 
cell body-synthesized GAP43, increases axonal growth (Donnelly et al., 2013). 
1.1.3.2 Axonal protein synthesis 
The discoveries that blocking general or specific protein synthesis selectively in axons 
inhibits regeneration (Verma et al., 2005), and that there is an association of decreased axonal 
protein synthesis with reduced regeneration ability in mature neurons (Jung et al., 2012), support 
a hypothesis that axonal protein synthesis is required in nerve regeneration. 
1.1.3.2.1 Evidence for axonal protein synthesis 
Axons were once believed to not have the ability to synthesize proteins, as early studies 
showed that axoplasm contained no detectable ribosomal RNA (Lasek et al., 1973). However, 
this interpretation was later challenged by evidence from more sensitive biochemical and 
microscopic methods showing the presence of ribosomal RNA (Rapallino et al., 1988), mRNAs 
(Giuditta et al., 1986), and ribosomal proteins (Tcherkezian et al., 2010; Walker et al., 2012) in 
axons. More convincing evidence supporting axonal protein synthesis came from experiments 
that showed endogenous (Eng et al., 1999) and exogenous (Van Minnen et al., 1997) mRNA can 
be translated in axons without somal input. 
Even though protein synthesis occurs in axons, there was a failure to detect the 
endoplasmic reticulum (ER) and Golgi apparatus in early ultrastructure studies (Yamada et al., 
1971; Bunge, 1973) raising the question about whether axons have the ability to process proteins. 
However, isolated axons do have the capacity to traffic axonally-synthesized proteins to the 
plasma membrane (Merianda et al., 2009) suggesting the existence of functional equivalents of 
the ER and Golgi apparatus in the axons, with additional studies revealing ER- and Golgi-
associated proteins within the axons (Jung et al., 2012; Gonzalez and Couve, 2014). 
Local synthesis of proteins allows axons to quickly respond to the changing environment 
before the arrival of soma-derived proteins. Indeed, even in the absence of neuronal cell bodies, 
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axons can respond to guidance cues (Campbell and Holt, 2001; Ming et al., 2002) and correctly 
grow toward their targets (Harris et al., 1987), indicating that axonal protein synthesis plays 
functional roles in regulating axon growth. 
1.1.3.2.2 Function of axonal protein synthesis in axon regeneration 
In vivo nerve injury results in increased axonal protein synthesis (Zheng et al., 2001; 
Verma et al., 2005) and enhanced regeneration in vitro (Smith and Skene, 1997; Verma et al., 
2005). Conversely, reducing axonal protein synthesis by protein synthesis inhibitors (Verma et 
al., 2005) or by blocking the axonal localization of mRNAs (Donnelly et al., 2011) inhibits axon 
regeneration after nerve injury. These findings indicate that the ability of axons to regenerate is 
associated with their ability to locally synthesize proteins. Indeed, olfactory receptor neurons, 
one of the few structures in the CNS that naturally regenerate axons (Costanzo, 1991), have 
proteins locally synthesized in their axons (Dubacq et al., 2009). 
Over 2,000 mRNAs have been identified in embryonic and adult peripheral axons (Gumy 
et al., 2011). Many of them have been shown to be locally translated and to regulate axon 
elongation, branching and regeneration as well as synapse formation and cell survival 
(Deglincerti and Jaffrey, 2012; Jung et al., 2012). It is interesting that axonal protein synthesis 
itself is regulated by proteins that are synthesized in the axons. Eukaryotic translation initiation 
factors eIF2B2 and eIF4G2 are locally synthesized in axons, which when blocked, inhibits 
general local protein synthesis and axon growth (Kar et al., 2013). The axon growth pattern is 
also regulated by local protein synthesis. Increasing axonally synthesized -actin results in 
highly branched axons, while increasing axonally synthesized GAP43 results in long axons with 
few branches, the latter consistent with that observed during regeneration (Donnelly et al., 2013). 
Mammalian target of rapamycin (mTOR), a protein that regulates global protein synthesis 
activity (Laplante and Sabatini, 2009), also regulates local protein synthesis in axons (Campbell 
and Holt, 2001). Blocking mTOR activity diminishes regeneration in vitro (Verma et al., 2005), 
while increasing mTOR activity has been shown to promote regeneration in vivo (Christie et al., 
2010). Unlike peripheral axons, injury to CNS axons results in down-regulation in global protein 
synthesis activity that can be prevented by genetic deletion of the negative regulators of mTOR. 
By increasing mTOR activity, the injured CNS neurons can regenerate axons (Park et al., 2008), 
although it is not clear whether axonal or general protein synthesis plays a more direct role in 
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this effect. Thus, this differential capacity for protein synthesis in the injured PNS versus CNS 
may be causally linked to their ability to regenerate axons. 
1.1.3.3 Retrograde transport of injury signals 
Besides functioning in the axons, axonally synthesized proteins can be retrogradely 
transported back to the cell bodies to deliver the injury signals and regulate a cell body response 
that is supportive for nerve regeneration. Retrograde transport is mediated by an interaction 
between cargo proteins and dynein, a motor protein that converts chemical potential energy 
stored in adenosine triphosphate (ATP) into the kinetic energy of movement (Schnapp and Reese, 
1989) along microtubules. Two major retrograde transport dynein interacting protein complexes 
have been identified: c-Jun amino-terminal kinase (JNK)-interacting protein (JIP) and importins 
(Rishal and Fainzilber, 2014). 
1.1.3.3.1 JIP and associated proteins 
JNK is one of the three family members of mitogen-activated protein kinases (MAPKs), 
with the other two being p38 MAPKs and extracellular signal-regulated kinases (ERKs) 
[reviewed in (Raman et al., 2007)], that has been shown to be required for successful axonal 
regeneration (Ruff et al., 2012). JIPs are a group of proteins that interact with activated JNK and 
bind to JNK cascade kinases. Sciatic nerve injury induces axonal activation of JNK, allowing 
activated JNK and JIP3 to then be retrogradely transported. This transport is mediated by an 
injury-enhanced interaction between JIP3 and dynactin (Cavalli et al., 2005), an essential 
component for dynein activity (Gill et al., 1991). The retrograde transport of JNK also requires 
the direct interaction between JIP3 and dynein, and this interaction potentially allows JIP3 to 
carry other retrograde cargos (Drerup and Nechiporuk, 2013), including dual leucine zipper 
kinase (DLK). 
DLK, a MAPK kinase kinase (MAPKKK) that can activate JNK, regulates axonal 
regeneration by improving the stability of mRNA that is required for local protein synthesis (Yan 
et al., 2009), and regulates injury responses by JIP3 (Klinedinst et al., 2013). DLK knockout 
impairs injury-induced enhanced axonal regeneration by blocking the retrograde transport of 
JIP3 and phosphorylated STAT3 (Shin et al., 2012), the latter being activated after PNS injury 
and retrogradely transported by importins (Ben-Yaakov et al., 2012). 
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1.1.3.3.2 Importins and associated proteins 
Importins are a group of proteins that regulate nucleocytoplasmic protein transport. They 
bind to the cargo proteins through a nuclear localization signal (NLS), a recognition motif in the 
cargo proteins, and then transport them from cytoplasm or axoplasm to the nucleus. Importins 
have two isoforms, importin  which directly binds to the NLS with low affinity, and importin  
which binds to importin  to increase its binding affinity to the NLS [review by (Goldfarb et al., 
2004)], helping cargo proteins to be retrogradely transported by dynein. The fact that axonal 
administration of synthetic NLS peptide can inhibit regenerative outgrowth by competitively 
blocking retrograde transport of injury signals (Hanz et al., 2003) supports an involvement of 
importins in retrograde transport within axons, with several different forms of importin  being 
found to associate with dynein in naïve and injured axons (Hanz et al., 2003). Pathology-
dependent creation of the high affinity NLS binding complex is accomplished by the fact that 
only the mRNA for importin  is found in the axon, with its translated protein being absent in 
naïve axons. Local translation of axonal importin  mRNA is triggered by axonal injury (Hanz et 
al., 2003), suggesting that the retrograde transport of injury signals is regulated by axonal protein 
synthesis. Subsequent experiments demonstrated that axonal knockout of importin  attenuates 
the cell body transcriptional response to nerve injury, and thereby delays regeneration (Perry et 
al., 2012). 
Several NLS-containing proteins have been identified to be transported through the 
importin-dynein system to regulate different neuronal activities. Cyclic adenosine 
monophosphate (cAMP) response element-binding protein 1 (CREB1) is translated in the axons 
in response to nerve growth factor (NGF), and retrogradely transported to promote neuronal 
survival (Cox et al., 2008); CREB2 is retrogradely transported after the stimuli inducing long-
term depression (a process that decreases the efficiency of synapses) (Lai et al., 2008); and 
Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-B) is transported via dynein 
in response to glutamatergic signals (activated by glutamine binding to its receptor) (Wellmann 
et al., 2001; Mikenberg et al., 2007). Proteins lacking NLSs were also found to be transported 
through dynein. Intermediate filament protein vimentin is locally translated in injured sensory 
axons (Perlson et al., 2005). Vimentin directly binds to importin  and phosphorylated/activated 
ERK, which does not have NLS, thus allowing ERK to be retrogradely transported through 
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importins after nerve injury (Perlson et al., 2005). One substrate of ERK is Jacob which is 
transported to nucleus to regulate cell survival and synaptic plasticity (Karpova et al., 2013). 
In injured peripheral neurons, retrograde signals produced at the site of injury or from 
cells associated with the nerve bind to receptors on the axons and are transported back to the cell 
body as signalling endosomes ultimately activating transcription of genes believed essential for 
survival and regeneration (Michaelevski et al., 2010). Alternatively, the absence of retrograde 
signals normally derived from target tissues that the injured axon is now disconnected from can 
also trigger alterations in gene expression [reviewed in (Verge et al., 1996; Harrington and Ginty, 
2013)]. Some of the injury-associated retrograde signals include transcription factors already 
localized in the nerve and activated by the injury and/or axonally synthesized in response to the 
injury. As such, transcription factors are important candidates for retrograde transport cargo 
proteins. Studies using proteomics and microarrays have identified 39 transcription factors as 
potential retrograde injury signal candidates (Michaelevski et al., 2010), and have verified this to 
be the case for STAT3 (Ben-Yaakov et al., 2012). Phosphorylation of STAT3 was found to occur 
in injured sciatic nerve, with this response extending back to the soma after injury, suggesting 
that the activated STAT3 acts as a retrograde signal (Lee et al., 2004). Further study revealed 
that axonal STAT3 is locally translated and activated in response to injury, and is then 
retrogradely transported through importins to regulate neuronal survival (Ben-Yaakov et al., 
2012). 
Since retrograde signals play an important role in altering neuronal response to injury, the 
formation of the retrograde transport complex must be tightly regulated. Indeed, the classical 
nuclear transport machinery is also found to be functional in the axons (Yudin et al., 2008). The 
ability of importins to transport their cargo is regulated by Ras-related nuclear protein (Ran), 
which cycles between a GDP-bound form (RanGDP) in the cytoplasm and a GTP-bound form 
(RanGTP) in the nucleus. The binding of RanGTP to importins in the nucleus prevents the 
interaction between importin  and importin causing the release of the cargo protein. The 
RanGTP-importins complex then translocates to the cytoplasm, where Ran binding protein 
(RanBP) dissociates the complex allowing RanGTP to be converted to RanGDP. RanGTP was 
found in naïve sciatic nerve axons, where it binds to importin  and dynein preventing retrograde 
transport from happening (Yudin et al., 2008). RanBP, which is only axonally translated after 
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injury, promotes RanGTP dissociation from importins, thereby allowing binding of importins to 
dynein and cargo proteins to form a retrograde transport complex. In support of such a role, 
blocking the activity of RanBP in injured axons has been shown to reduce the cell body response 
to injury (Yudin et al., 2008; Yudin and Fainzilber, 2009). 
While nerve injury is linked to dramatic increases in protein synthesis at both the axon 
and soma level, only properly folded proteins are transported from the endoplasmic reticulum 
(ER) to their destination, while misfolded or unfolded proteins are targeted for refolding or 
degradation. The accumulation of unfolded proteins in the ER triggers several signal pathways, 
collectively known as unfolded protein response (UPR). 
1.2 Unfolded protein response 
In eukaryotic cells, secreted, plasma membrane and organelle proteins fold and mature in 
the lumen of endoplasmic reticulum (ER) before they can be delivered to their destination as 
correctly functioning proteins. After being synthesized in the ribosome, unfolded polypeptide 
chains enter the ER. The amount of newly synthesized polypeptide entering the ER rapidly 
changes in response to the cell growth state and environmental conditions. To ensure correct 
protein folding under different loads, cells change the ability of protein folding according to the 
requirement. This balance is achieved through several signalling pathways that sense the protein 
folding status in the ER and convey this information to the other components of the cell. 
Collectively, these signal pathways are referred to as the unfolded protein response (UPR) 
[reviewed in (Ron and Walter, 2007)]. 
The imbalance between the unfolded protein in the ER and the cellular protein folding 
capacity ultimately causes ER stress. The UPR helps cells to cope with this stress and regain 
balance by increasing the capacity of ER to correctly fold the unfolded proteins and reduce 
protein synthesis and translocation to the ER [reviewed in (Walter and Ron, 2011)]. However, if 
cells fail to re-establish homeostasis, then the UPR triggers apoptosis to protect organisms from 
the toxicity caused by accumulated unfolded proteins. 
1.2.1 UPR pathways 
Three different, but interactive, pathways have been identified to regulate the UPR. Each 
pathway utilises a different ER stress transducer and forms a distinct arm of the UPR. The three 
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signal transducers are inositol-requiring protein-1 (IRE1), protein kinase RNA-like ER kinase 
(PERK), and activating transcription factor 6 (ATF6). 
1.2.1.1 IRE1 
IRE1 is the first identified ER stress transducer (Cox et al., 1993) and is the most 
conserved and the only UPR pathway in lower eukaryotes (Mori, 2009). IRE1, a type 1 ER-
resident transmembrane protein, has a cytoplasmic domain containing a kinase module and an 
endoribonuclease (RNase) domain, and an ER lumenal domain which binds to a molecular 
chaperone protein, glucose-regulated protein 78 (GRP78). In yeast, IRE1 is activated by the 
direct binding of unfolded proteins to its ER lumenal domain (Gardner and Walter, 2011). In 
mammalian cells, the activation of IRE1 depends on dissociation of GRP78 rather than direct 
interaction with unfolded proteins (Zhou et al., 2006; Oikawa et al., 2009). 
Upon receiving the activation signal, IRE1 oligomerizes allowing the kinase domain to 
undergo trans-autophosphorylation (Li et al., 2010). Instead of generating a conventional cascade 
of sequential kinase activity (Papa et al., 2003), the phosphorylation of IRE1 triggers its RNase 
activity, resulting in the endonucleolytic cleavage of X-box binding protein 1 (XBP1) mRNA 
(Calfon et al., 2002), and endonucleolytic decay of a specific subset of mRNAs (Hollien and 
Weissman, 2006; Han et al., 2009). The latter reduces the flow of newly synthesized 
polypeptides into the stressed ER. 
Both the precursor and the spliced XBP1 mRNA are translated in metazoans (Yoshida et 
al., 2006), but their encoded proteins have different functions due to the splicing-mediated 
reading frame shift. The spliced form of XBP1 (XBP1s) functions as an activator of the UPR and 
is translated from the spliced mRNA, and this translation increases when IRE1 is activated 
(Calfon et al., 2002). In contrast, the translation of the unspliced form of XBP1 (XBP1u) from 
the precursor XBP1 mRNA increases when IRE1 is inactivated and this unspliced form functions 
as an inhibitor of the UPR (Yoshida et al., 2006). XBP1u binds to XBP1s, and the complex is 
rapidly degraded. Thus, XBP1u is a negative feedback regulator of XBP1s, terminating the 
transcription of target genes of XBP1s during the recovery phase of ER stress (Yoshida et al., 
2006). 
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XBP1s is a basic leucine zipper (bZIP) transcription factor that regulates target gene 
expression via their ER stress response element (ERSE) (Yoshida et al., 1998) and UPR element 
(UPRE) (Cox and Walter, 1996). XBP1s regulates phospholipid biosynthesis and ER biogenesis 
(Sriburi et al., 2004), and also increases expression of UPR-related genes (Lee et al., 2003). 
These genes include SRP54 which helps the entry of newly synthesized polypeptides into the ER 
(Rapiejko and Gilmore, 1997); ERdj4 and EDEM which facilitate the degradation of misfolded 
proteins (Hosokawa et al., 2001; Lai et al., 2012); and protein disulfide isomerase which 
catalyzes protein folding.  
1.2.1.2 PERK 
Similar to IRE1, PERK is a type I ER transmembrane protein. It has an ER lumenal 
stress-sensing domain that is functionally interchangeable with the lumenal domain of IRE1 
(Bertolotti et al., 2000) and a cytoplasmic domain containing protein kinase activity (Harding et 
al., 1999). The activity of PERK is also triggered by the dissociation of GRP78 from its lumenal 
domain (Bertolotti et al., 2000), which leads to oligomerization of PERK and trans-
autophosphorylation of its kinase domain. Activated PERK phosphorylates eukaryotic translation 
initiation factor 2 (eIF2) (Harding et al., 1999), an essential factor in initiating protein translation. 
Phosphorylation of eIF2 inhibits general protein translation at the initiation stage, thereby 
reducing the flux of protein entering the already stressed ER. 
During the shutoff of global protein synthesis, certain proteins are still being translated in 
order to help the stressed cell regain homeostasis. One of those proteins is ATF4, a bZIP 
transcription factor, whose mRNA contains small open reading frames in the 5’-untranslated 
region, allowing translation to occur even when eIF2 is phosphorylated (Lu et al., 2004). ATF4 
regulates gene expression by binding to CCAAT-enhancer binding protein-activating 
transcription factor response elements (CARE) (Fawcett et al., 1999). Two key target genes 
driven by ATF4 are CCAAT/enhancer-binding protein homologous protein (CHOP) (Fawcett et 
al., 1999) and the growth arrest and DNA damage-inducible protein 34 (GADD34) (Ma and 
Hendershot, 2003). 
CHOP is a transcription factor that promotes the transcription of apoptosis-associated 
genes [reviewed in (Sano and Reed, 2013)]. Thus, while the PERK pathway protects cells 
against ER stress by reducing protein synthesis, it also produces signals leading to apoptosis. 
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GADD34 binds to type I protein phosphatase (PP1) (Connor et al., 2001) and induces 
dephosphorylation of eIF2 (Novoa et al., 2001), allowing protein synthesis to recover (Ma and 
Hendershot, 2003) and therefore serving as negative feedback regulator of PERK pathway. 
1.2.1.3 ATF6 
The third ER stress transducer ATF6 is a type II ER transmembrane protein. ATF6 has an 
ER lumenal domain that interacts with GRP78 (Haze et al., 1999) and a cytoplasmic domain that 
contains a bZIP motif (Hai et al., 1989). Under ER stress conditions, ATF6 dissociates from 
GRP78, unmasking Golgi localization signals that facilitate its translocation from the ER to the 
Golgi apparatus (Shen et al., 2002) through coat protein II (COPII) transport vesicles (Schindler 
and Schekman, 2009). This translocation is also regulated by the glycosylation status (Hong et 
al., 2004) and the disulfide bonds status (Nadanaka et al., 2007) of ATF6. After arrival in the 
Golgi, ATF6 is cleaved by site-1 protease (S1P) and site-2 protease (S2P), which releases its N-
terminal cytoplasmic domain (Ye et al., 2000) that eventually moves into the nucleus to function 
as a bZIP transcription factor. 
ATF6 regulates target gene expression by binding to an ERSE (Yoshida et al., 2000). The 
key target genes driven by ATF6 are UPR-related genes, including GRP78 (a molecular 
chaperone), Derlin-3 (an ER-associated degradation system-associated protein) (Adachi et al., 
2008), CHOP and XBP1 (Yoshida et al., 2000). ATF6 is also involved in the regulation of ER 
biogenesis and phospholipid biosynthesis (Bommiasamy et al., 2009; Maiuolo et al., 2011). 
Several other proteins that have structure similar to ATF6 have been identified. These 
ER-transmembrane, bZIP transcription factors include Luman/CREB3 (Lu et al., 1997), 
OASIS/CREB3L1 (Honma et al., 1999), CREB3L2 (Storlazzi et al., 2003), CREB3L4 
(Nagamori et al., 2005) and CREBH (Zhang et al., 2006). These ATF6-like proteins appear to 
regulate the UPR in specific organs and tissues as they differ in respect to activating stimuli, 
tissue distribution and response element binding [reviewed in (Asada et al., 2011)]. 
1.2.1.4 Crosstalk between UPR pathways 
While IRE1, PERK and ATF6 function individually, these three pathways of the UPR 
communicate with each other in ER-stressed cells. IRE1 and PERK crosstalk with each other 
through their downstream targets XBP1 and eIF2, respectively. XBP1 up-regulation is an 
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important event in the UPR. However, in PERK knockout cells, XBP1 is not up-regulated under 
ER stress (Calfon et al., 2002) due to the lack of eIF2 phosphorylation (Huang et al., 2010). 
Further studies demonstrate that the mechanism behind the XBP1 up-regulation is via an eIF2 
phosphorylation stabilization of the mRNA of XBP1 (Majumder et al., 2012). 
As mentioned above, IRE1 regulates the UPR through splicing the mRNA of XBP1. The 
fact that the transcription of XBP1 can be driven by ATF6 (Yoshida et al., 2001) links IRE1 and 
ATF6 pathways. Indeed, in Caenorhabditis elegans, deletion of either ire-1 or xbp-1 is 
synthetically lethal with deletion of atf-6 (Shen et al., 2005), indicating a functional redundancy 
between the IRE1 and ATF6 pathways. Although the bZIP transcription factors XBP1s and 
ATF6 regulate distinct sets of UPR-related genes, they can form heterodimers to promote the 
transcription of genes involved in ER-associated protein degradation (Yamamoto et al., 2007). 
ER stress induces the cleavage of ATF6 to generate the active N-terminal fragment of 
ATF6. However, in PERK knockout cells, ATF6 activation is not sustained under ER stress and 
as a consequence its target gene, GRP78 remains expressed at a lower level (Adachi et al., 2008). 
This indicates the existence of crosstalk between PERK and ATF6 pathways. Indeed, the PERK 
pathway regulates the activity of ATF6 and its target genes by facilitating ATF6 synthesis, as 
well as its transport from the ER to the Golgi (Teske et al., 2011), the latter being a crucial step 
in ATF6 activation. 
1.2.2 UPR and cholesterol 
Besides transcriptionally and translationally regulating proteins that function in coping 
with ER stress, the UPR also contributes to cellular lipid homeostasis and formation of ER 
membranes. This is supported by observations that the UPR can be activated by phospholipid 
depletion (Cox et al., 1997) and membrane lipid saturation (Volmer et al., 2013). As well as 
induction of the UPR up-regulates many rate-limiting enzymes in lipid biogenesis (Travers et al., 
2000) indicating that the UPR participates in lipid metabolism. The expansion of the ER 
membrane is another key event in the cellular response to accumulated unfolded proteins. This 
generation of new ER membrane requires UPR activity and lipid biosynthesis (Schuck et al., 
2009). The levels of membrane phospholipids and the volume of the ER are increased when 
XBP1 is overexpressed (Sriburi et al., 2004). Intriguingly, sterol regulatory element-binding 
proteins (SREBPs), transcription factors that sense sterol sufficiency and regulate sterol 
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biosynthesis, are controlled by the UPR [reviewed in (Colgan et al., 2011)] and share the same 
activating machinery with the UPR (Ye et al., 2000). 
1.2.2.1 SREBP and cholesterol 
Cholesterol, which regulates membrane fluidity and permeability, is an essential 
structural component of the cell membrane. However, excess cholesterol is toxic to the cells 
[reviewed in (Maxfield and Tabas, 2005)]. Therefore its cellular levels are tightly regulated. 
Exogenous cholesterol is absorbed by cells through the interaction between low-density 
lipoprotein (LDL) receptor and LDL which is associated with cholesterol. Endocytosis of the 
LDL receptor bound to LDL brings cholesterol into the cells. Besides obtaining cholesterol 
exogenously, cells also have the ability to synthesis cholesterol endogenously. The cholesterol 
biosynthetic pathway requires several enzymes that are regulated by SREBPs, including HMG-
CoA reductase (Wang et al., 1994), a rate-limiting enzyme of cholesterol synthesis. 
SREBPs are ER-associated transcription factor precursors. In the presence of cholesterol, 
SREBPs are associated with SREBP cleavage activating protein (SCAP) (Hua et al., 1996a) and 
localized to the ER membrane through the interaction between SCAP and ER resident protein 
insulin-induced gene (INSIG) (Yabe et al., 2002; Yang et al., 2002). Decreased cholesterol levels 
triggers the dissociation of INSIG and SCAP (Yang et al., 2002), allowing the SREBP and SCAP 
complex to be transported to the Golgi apparatus (Nohturfft et al., 2000) through COPII vesicles 
(Espenshade et al., 2002). Upon arrival at the Golgi, SREBP undergoes proteolytic cleavage by 
S1P and S2P (Wang et al., 1994; Hua et al., 1996b; Sakai et al., 1996), and the cytoplasmic 
portion of SREBP is released and transported to the nucleus to function as transcription factor. 
SREBP regulates target gene expression by binding to the sterol regulatory element. The 
two key target genes involved in cholesterol metabolism are LDL receptor (Yokoyama et al., 
1993), which mediates cellular cholesterol uptake, and HMG-CoA reductase (Wang et al., 1994), 
which is the rate-controlling enzyme in the cholesterol synthesis pathway. SREBP also regulates 
the expression of PCSK9 (Jeong et al., 2008), which promotes the internalization and 
degradation of LDL receptor (Seidah et al., 2006); therefore, serving as a negative feedback 
regulator in cholesterol metabolism. 
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Three isoforms of SREBPs, SREBP-1a, SREBP-1c (Yokoyama et al., 1993), and 
SREBP-2 (Hua et al., 1993), have been identified. STEBP-1a and 1c are produced from a single 
gene through alternative translation start sites (Hua et al., 1995), while SREBP-2 is produced 
from a separate gene (Miserez et al., 1997). Forced expression of SREBP-1a increases the 
expression of genes involved in cholesterol, fatty acid, triglycerides, and phospholipids synthesis 
(Shimano et al., 1996; Horton et al., 2003). SREBP-1c, which is less active than isoform 1a, 
induces expression of lipogenesis (Shimano et al., 1997) and glycolysis (Foretz et al., 1999) 
genes. SREBP-2 differs in that it appears to more selectively activate genes involved in 
cholesterol synthesis, althoufgh moderate induction of fatty acid synthesis genes has been 
observed in SREBP-2 overexpression mice (Horton et al., 1998). 
1.2.2.2 UPR and SREBP activation 
The observations that SREBP and ATF6 share the same proteolytic mechanism 
(regulated intramembrane proteolysis) and ER to Golgi transport machinery suggest that a 
correlation exists between the UPR and SREBP. Indeed, increased UPR causes the activation of 
SREBP and accumulation of cholesterol (Werstuck et al., 2001). Elevated cholesterol level also 
activates the UPR and induces apoptosis through the activation of CHOP, a target of ATF6 (Feng 
et al., 2003). 
The UPR regulates the SREBP activity through several mechanisms. General protein 
synthesis is suppressed by eIF2 phosphorylation under ER stress, which reduces the expression 
of INSIG (Bobrovnikova-Marjon et al., 2008). Decreased INSIG allows SREBP to be released 
from the ER and to be activated (Lee and Ye, 2004; Bobrovnikova-Marjon et al., 2008). On the 
other hand, forced expression of GRP78 inhibits ER stress-induced SREBP activity (Werstuck et 
al., 2001) through the interaction between these two proteins (Kammoun et al., 2009). 
While the UPR shows broad influences on protein and lipid homeostasis, the discovery of 
a number of ATF6-like proteins, including Luman/CREB3, may help us understand the 
mechanisms by which the UPR is activated by different stimuli in specific tissues. 
1.3 Luman 
Luman (also known as CREB3 or LZIP, hereafter referred to as Luman) was first 
identified through its association with the host cell factor (HCF, a protein involved in regulation 
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of herpes simplex virus infection cell cycle) (Freiman and Herr, 1997; Lu et al., 1997). Luman is 
a cyclic AMP response element (CRE)-binding protein and belongs to the bZIP transcription 
factor superfamily. The functions of Luman that have been described to date include regulation 
of the UPR, dendritic cell maturation and cell migration (see below). 
1.3.1 Structure and activity regulation 
Luman has a similar structure to ATF6, one of the three ER stress transducers. It has an 
ER transmembrane domain that allows binding to the ER, a bZIP domain allowing DNA binding, 
and a transcription activation domain. The transcription activation domain contains three 
elements: two LxxLL motifs, which are present in many transcription factors and cofactors 
mediating protein-protein interactions, and one HCF-binding motif (Luciano and Wilson, 2000). 
An additional amino acid sequence adjacent to the N-terminal end of the bZIP domain is 
conserved in other ATF6-like, bZIP transcription factors, including OASIS/CREB3L1, 
CREB3L2, CREB3L4 and CREBH. But this sequence is not found in typical bZIP transcription 
factors, including ATF6 [reviewed in (Asada et al., 2011)]. The ER lumenal domain of Luman 
contains an S1P cleavage sequence and a partial S2P cleavage sequence (Raggo et al., 2002), 
indicating it is processed by regulated intramembrane proteolysis. However, the ER lumenal 
domain of Luman shows little homology to that of ATF6, suggesting different mechanisms in 
sensing stress signals and transport from the ER to the Golgi. 
The inactive form of Luman binds to the ER. After receiving activation signals, Luman 
translocates to the Golgi where it is cleaved by S1P and an unidentified protease. The proteolytic 
cleavage releases the cytoplasmic N-terminal portion of Luman with all the known regulatory 
domains, that eventually moves into the nucleus to function as a transcription factor (Raggo et al., 
2002). Luman regulates transcriptional activity through binding to the cAMP response element, 
UPRE and ERSE II in the promoter region of target genes. Luman recruitment factor (Audas et 
al., 2008) and Jun activation domain-binding protein 1 (DenBoer et al., 2013) are two proteins 
that negatively regulate the activity of Luman by promoting its degradation, consistent with 
active transcription factors being usually quickly degraded after their functions are accomplished. 
1.3.2 Function 
The observation that forced expression of Luman protects cells against ER stress-induced 
apoptosis (Liang et al., 2006) indicates a role for Luman in regulating the UPR. Indeed, Luman 
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promotes the transcription of two UPR-related genes, ER degradation-enhancing alpha-
mannosidase (EDEM) (DenBoer et al., 2005), which contains UPRE in its promoter region, and 
homocysteine-induced endoplasmic reticulum protein (HERP) (Liang et al., 2006), which 
contains ERSE II in its promoter region. Both EDEM (Hosokawa et al., 2001) and HERP (Kim 
et al., 2008) are involved in the ER-associated protein degradation pathway, which suggests that 
Luman regulates the UPR by facilitating the degradation of misfolded proteins. 
Through networking with other proteins, the functions of Luman extend beyond 
regulating the UPR. Luman participates in cell migration through interacting with different 
chemokine receptors. It regulates monocyte migration by binding to CCR1 (Ko et al., 2004), 
enhancing the activity of NF-B (Jang et al., 2007), and increasing the expression of CCR1 and 
CCR2 (Sung et al., 2008). Luman also regulates the migration of breast cancer cells by 
promoting the expression of CXCR4 (Kim et al., 2010). In addition, the interaction between 
Luman and DC-specific transmembrane protein is involved in dendritic cell maturation (Eleveld-
Trancikova et al., 2010), and interplay between Luman and ADP ribosylation factor 4 mediates 
cellular response to Golgi stress (Reiling et al., 2013). 
Despite the various reported functions of Luman, little is known about its role in the 
nervous system other than that it is expressed by sensory neurons and is involved in reactivation 
of the herpes simplex virus (HSV), a process that normally occurs in response to environmental 
stresses (Lu and Misra, 2000). In preliminary studies by our labs, expression of Luman in DRG 
neurons was found to be regulated by axonal injury and also co-localized with importin 1 in the 
injured axons (Hasmatali et al., 2011 Society for Neuroscience Abstract 438.1) suggesting a 
potential role in retrograde signaling. Such a role is further supported by the fact that the Luman 
transcript was isolated, but not validated, in a transcriptome analysis of injured sensory axons 
(Gumy et al., 2011). Thus, I hypothesized that axonal Luman is an ER-localized transcription 
factor that transduces injury stress signals from remote axonal locations back to the neuronal cell 
body where it serves to regulate expression of regeneration-associated transcripts. Understanding 
the role that Luman plays in regulating a cell body response supportive of peripheral nerve 
regeneration is the main goal of this thesis and elucidation of this role was achieved by 
addressing the objectives below. 
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1.4 Thesis objectives 
Objective 1: clone and characterize the rat Luman gene so that the function of Luman can be 
studied in a rat model; 
Objective 2: to characterize the role of axonally-derived Luman in the response to peripheral 
nerve injury and determine its potential role in regulation of axonal regeneration; 
Objective 3: to elucidate the mechanism by which Luman regulates axonal regeneration. 
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2 Material and methods 
2.1 Animals, surgical procedure, and tissue preparation 
All animal procedures were conducted in accordance with the Canadian Council on 
Animal Care and approved by the University of Saskatchewan Animal Research Ethics Board. 
Adult male Wistar rats (Charles River Laboratories) weighing ~250 grams were housed at room 
temperature on a 12-h light-dark cycle and had free access to food and water.  
2.1.1 Sciatic nerve crush injury 
The animals were anesthetised with 2 % Isoflurane. Animals were given pre- and post-
operative analgesics subcutaneously (Buprenorphine 0.05 mg/kg). Approximately 5 mm of the 
sciatic nerve was exposed at the mid-thigh level, followed by crush injury using a fully closed 
smooth-jaw ultra-fine hemostat (0.6 mm tip) for 10 sec. 
 
Figure 2.1.1 Sciatic nerve injury model 
 
2.1.2 Perfusion 
Deeply anesthetised rats (Sodium Pentobarbital, 70 mg/kg) were perfused via the aorta 
with cold PBS and 4 % paraformaldehyde. Right and left L4, 5, 6 DRGs or sciatic nerve 
segments were dissected, postfixed and cryoprotected in 20 % sucrose in PBS overnight. Paired 
experimental and control tissues were mounted in the same cryomold, covered with OCT 
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compound (Tissue-Tek) and frozen in isopentane at -80 °C. Transverse serial sections were cut at 
8 m on a cryostat (Microm) and collected on ProbeOn Plus slides (Fisher Scientific). 
2.2 Cell culture, transfection, and enzymatic assay 
2.2.1 Cell lines 
Vero cells or HEK 293 cells were cultured in Dulbecco's Modified Eagle Medium 
(DMEM) supplemented with 10 % newborn calf serum or 10 % fetal bovine serum, 100 unit/ml 
penicillin and 100 mg/ml streptomycin at 37 °C in humidified air with 5 % CO2. One day prior to 
transfection, Vero cells were seeded into six-well plates at a concentration of 5×105/well. One g 
of pcDNA3.1, pcLuman, pcRatLuman, or pcGFP-Lu-RFP was cotransfected with 100 ng of 
pCAT3BATF6 by using Lipofectamine 2000 (Life Technologies). Chloramphenicol 
acetyltransferase (CAT) activity was measured 24 h post transfection, using the CAT Enzyme-
linked immunosorbent assay (ELISA) kit (Roche). 
2.2.2 Adult DRG culture 
Rat DRG were treated with 0.25 % collagenase (1 h, 37 °C) and dissociated with 2.5 % 
trypsin (30 min, 37 °C) before plating on laminin (1 g/mL) and poly-D-lysine-coated (25 
g/mL) coverslips at 104 cells per well in a 6-well plate (BD Biosciences) in DMEM 
supplemented with 10 ng/ml of 2.5S NGF (Cedarlane Labs). Cytosine β-D-arabinofuranoside 
(Ara-C, 10 M) was added to inhibit proliferation of non-neuronal cells. 
In select experiments MG-132 (Sigma, 5 M) and chloroquine (Sigma, 100 M) were 
added to inhibit protein degradation; cycloheximide (Sigma, 10 g/mL) to inhibit translation; or 
colchicine (Sigma, 10 g/mL) to inhibit microtubule polymerization. NLS peptide (Enzo, 
AAVALLPAVLLALLAPVQRKRQKLMP, 50 g/ml) was added to compete with Luman for 
binding to the importin transport complex. Mismatch NLS peptides (Enzo, 
AAVALLPAVLLALLAPVQRNGQKLMP, 50 g/ml) served as control. 
To study the effect of lowered Luman expression, some DRG cultures were transfected 
with Luman siRNA (Integrated DNA Technologies) or negative control nontargeting siRNA 
using Lipofectamine RNAiMAX Reagent (Life Technologies). Luman knockdown efficiency 
was assessed by Western blot. 
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To monitor changes in cholesterol biosynthesis in cultured neurons, total and free cellular 
cholesterol mass was determined using an enzymatic fluorometric assay, employing the Amplex 
Red Cholesterol assay kit (Life Technologies). 
2.3 Culture methods for isolation of axons 
2.3.1 Transwell insert 
Isolation of DRG axons was as previously described (Zheng et al., 2001) with the minor 
modification, of using transwell insert membranes with 3 m. Dissociated DRG neurons were 
plated onto a tissue culture insert containing a polyethylene tetraphthalate (PET) membrane with 
3 m pores (BD Biosciences) that had been coated with poly-L-lysine and laminin. To isolate 
axons, the top membrane surface was scraped with a cotton-tipped applicator (Q-tips). For 
isolation of cell bodies, the surface underneath the membrane was scraped. 
2.3.2 Compartmented explant culture 
DRGs were cut into 4-5 smaller pieces and explant cultures were grown in 
compartmented culture chambers [adapted from (Vogelaar et al., 2009)] whereby individual 
DRG explants can extend axons into isolated right or left compartments, allowing for the 
differential treatment of the neurites under control or experimental conditions. DRG explants 
(15–20 per well) were plated in a row on top of scratches made with a pin rake (Tyler Research 
Corporation) in 6-well plates coated with poly-D-lysine (25 g/mL) and laminin (1 g/mL) in 
DMEM supplemented with 50 ng/mL NGF. The volume of medium was kept low for the first 
day to better hold the explants to the culture surface via surface tension. After 1 day in vitro 
(DIV), a compartmented insert cut from 1 mm thick medical grade silicon sheet (Rubber Sheet 
Roll) was placed into the dish creating leak proof compartments. Ara-C (10 M) was added to 
abolish cell proliferation. The cultures were maintained for 7 days, with Ara-C treatment every 
other day. 
2.4 Gene expression analysis 
2.4.1 Nucleic acid sequence 
2.4.1.1 Primers for qRT-PCR 
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Table 2.1 shows the oligonucleotide sequence (Integrated DNA Technologies) of primers 
used in qRT-PCR assay. 
Table 2.1 Primers for qRT-PCR 
 
Gene Upstream primers 
Downstream primers 
18S rRNA TCCTTTGGTCGCTCGCTCCT 
TGCTGCCTTCCTTGGATGTG 
-actin CCGTAAAGACCTCTATGCCAACA 
CGGACTCATCGTACTCCTGCT 
Calnexin TTTGGGTGGTCTACATTC 
CTTCTTCGTCCTTCACAT 
CHOP TGGAAGCCTGGTATGAGGAC 
TGCCACTTTCCTCTCGTTCT 
-actin ACACTGCGTTTCTTTCCG 
AATGCCGTGCTCAATAGG 
GAPDH GGTGCTGAGTATGTCGTGGAGTC 
GTGGATGCAGGGATGATGTTCT 
GRP78 GGCTTGGATAAGAGGGAAGG 
GGTAGAACGGAACAGGTCCA 
Insig1 ACAGTGGGAAACATAGGAC 
TGAACGCATCTTTAGGAG 
Insig2 AGCAACCGTTGTCACCCA 
TCCCATCGTTATGCCTCC 
Luman TGTGCCCGCTGAGTATGTTG 
AGAAGGTCGGAGCCTGAGAA 
Mbtps2 GTCCCGTTACTAATGTGC 
CAAACTTGAGTGGCTTCA 
SREBP1 CGCTACCGTTCCTCTATCA 
CTCCTCCACTGCCACAAG 
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Gene Upstream primers 
Downstream primers 
Ubxn4 GGAACGGTGCTTTATCCA 
ATCTTGAGTCCGCAGTCG 
XBP1 TCAGACTACGTGCACCTCTGC 
TAAGGAACTGGGTCCTTCT 
XBP1 spliced TCTGCTGAGTCCGCAGCAGG 
TAAGGAACTGGGTCCTTCT 
 
2.4.1.2 Primers for cloning rat Luman 
Upstream: GAGTTTCTATCCATAAATATTCCAA 
Downstream: CTGAGGACACCCCATATCCTCACAC 
2.4.1.3 Probe sequences used for in situ hybridization: 
CHOP: CTCTTCAGCAAGCTGTGCCACTTTCCTCTCATTCTCCTGCTCCTTCTC 
GRP78: GTATCCTCTTCACCAGTTGGGGGAGGGCCTCCACTTCCATAGAGTTTG 
Luman: CAATTCTTGCACGGAGTTCTCGGAAGGCGACAGCTCCAAGTCCAGGGG 
2.4.1.4 siRNA sequence for Luman knockdown 
CGACUGGGAGGUAGAGGAUUUAC 
2.4.2 Cloning rat Luman coding sequence 
tBLASTn analysis with the amino acid sequence of mouse Luman amino acid sequence 
(NCBI Reference Sequence: NP_038525.2) was performed against the rat genome sequence. A 
potential rat mRNA (TL0ABA47YN07 mRNA sequence, GenBank: FQ219084.1) was identified 
that codes for rat Luman. Total RNA was extracted from adult Wistar rat DRG using the RNeasy 
Kit (Qiagen) and converted to cDNA using the QuantiTect Rev. Transcription Kit (Qiagen). 
cDNA was amplified with a thermal cycler (DNA Engine) by 30 cycles of PCR (30 s at 94°C, 60 
s at 55°C, and 90 s at 72°C). The PCR product was TOPO cloned into pCR2.1-TOPO (Life 
Technologies) to form pCRLuman and the nucleotide sequence of the insert was determined. 
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2.4.3 Plasmid 
The construction of pcLuman (Lu et al., 1997), a plasmid expressing human Luman in 
mammalian cells, and the CAT reporter plasmid pCAT3BATF6 (Misra et al., 2005), with the 
coding sequences for chloramphenicol acetyl transferase (CAT) following five copies of the 
UPRE (unfolded protein response element)-containing oligonucleotide, have been previously 
described. 
 A plasmid that expresses rat Luman in mammalian cells, pcRatLuman, was constructed 
by transferring the coding sequence of rat Luman from pCRLuman to pcDNA3.1 (Life 
Technologies) at the EcoRI site. The insert orientation was checked by digestion with KpnI. 
The coding sequences for enhanced green fluorescent protein (GFP) and red fluorescent 
protein (RFP) were fused in frame to the 5’ terminus and 3’ terminus of the rat Luman gene, 
respectively, by using In-Fusion HD Cloning Plus (Clontech). The fused gene was cloned into 
pcDNA3.1 to generate pcGFP-Lu-RFP. 
2.4.4 Adenovirus preparation 
The open reading frame of the GFP-Luman-RFP fused protein was inserted into the 
Adeno-X Viral DNA vector as per the manufacturer’s instruction (Clontech). Adenovirus, named 
Ad/GFP-Lu-RFP, was grown and purified using the Adeno-X Expression System (Clontech). 
For in vitro infection, neurons were infected with 100 multiplicity of infection (MOI) 48 h prior 
to axotomy. For in vivo infection, 15 L of Ad/GFP-Lu-RFP (2×1011 PFU/mL; N=4) or control 
Adeno-LacZ (expressing E. coli beta-galactosidase; 2×1011 PFU/mL; N=2) was injected 
intrathecally via a sterile silicon catheter inserted at the lumbar sacral junction such that the tip of 
the catheter delivering the vector was at the L5 DRG level. Rats were left 1 week in order to 
transduce the sensory neurons before 48 h sciatic nerve crush injury at the midthigh level. 
2.4.5 Real-Time Quantitative Reverse Transcription PCR (qRT-PCR) analysis 
Total RNA was isolated using the RNeasy Kit (Qiagen). The quality of RNA was 
analyzed by electrophoresis using the Agilent 2100 bioanalyzer (Agilent Technologies). One g 
of total RNA with RNA integrity number (RIN) > 9 was converted to cDNA using the 
QuantiTect Rev. Transcription Kit (Qiagen). cDNAs were amplified with a RT-PCR machine 
(Stratagene). The levels of housekeeping genes GAPDH, -actin, and 18S rRNA were used as 
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internal control to verify the qRT-PCR reaction. A non-template control was included in each set 
of reactions. 
2.4.6 In Situ hybridization histochemistry 
Oligonucleotide probe complementary to and selective for Luman, GRP78, and CHOP 
mRNA were synthesized (Integrated DNA technologies). The probes were labeled at the 3’-
terminus with -[35S] dATP (PerkinElmer) using terminal deoxynucleotidyl-transferase (Life 
Technologies), and purified through QIAquick nucleotide removal kit (Qiagen). 
The sections were hybridized at 43°C for 18 h before processing for radioautography by 
coating in NTB nuclear track emulsion (Kodak), and exposed for 14 days before developing in 
D-19 (Kodak) and viewing under darkfield and brightfield conditions. 
The specificity of hybridization signal for the probes were confirmed using serial sections 
hybridized with radio-labeled probe, radio-labeled probe with a 1000-fold excess of unlabeled 
probe (which effectively competed all specific binding of labeled probe), or labeled probe with a 
1000-fold excess of another, dissimilar unlabeled probe of the same length and similar GC 
content (which did not alter the hybridization signal pattern observed using the labelled probe 
alone). 
2.4.7 qRT-PCR array 
Unfolded protein response qRT-PCR arrays were purchased (SABiosciences). The array 
contained primers for 84 gene transcripts involved in the UPR. The array also contained controls 
for genomic DNA contamination and reverse transcriptase efficiency. The results were analyzed 
by using a SABiosciences online resource RT2 profiler. To confirm the results of the qRT-PCR 
array, primers were designed for genes down-regulated for more than 2 fold. 
2.5 Protein expression analysis 
2.5.1 Antibodies 
2.5.1.1 Primary antibodies 
Table 2.2 lists the primary antibodies used in Western blot and Immunofluorescence. 
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Table 2.2 Primary antibodies employed 
Target Host species 
Western blot 
dilution 
Immunofluorescence 
dilution 
Source 
 III-tubulin Mouse/Rabbit 1:1,000 1:1,000 Millipore 
Calnexin Rabbit 1:1,000 1:50 CST 
CHOP Mouse 1:1,000 1:250 CST 
GAPDH Mouse 1:2,000 
 
Novus Biologicals 
GRP78 Rabbit 1:1,000 1:200 CST 
importin  Mouse 1:1,000 
 
Sigma 
importin  Mouse 1:1,000 1:200 Thermo Scientific 
IRE1 Rabbit 1:1,000 
 
CST 
Lamin B Goat 1:200 
 
Santa Cruz 
Luman Rabbit 1:400 1:400 Misra’s lab 
PDI Rabbit 1:1,000 
 
CST 
PERK Rabbit 1:1,000 
 
CST 
 
2.5.1.2 Secondary antibodies 
Table 2.3 lists the secondary antibodies used in Western blot and Immunofluorescence. 
Table 2.3 Secondary antibodies 
Target Host species Conjugate Dilution Source 
Goat Donkey Alexa Fluor 680 1:10,000 Life Technologies 
Mouse Donkey DyLight 488 1:1,000 Jackson ImmunoResearch 
Mouse Donkey DyLight 594 1:1,000 Jackson ImmunoResearch 
Mouse Goat IRDye 680 1:10,000 LI-COR Biosciences 
Mouse Goat IRDye 800 1:10,000 LI-COR Biosciences 
Rabbit Donkey Alexa Fluor 350 1:500 Life Technologies 
Rabbit Goat DyLight 488 1:1,000 Jackson ImmunoResearch 
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Target Host species Conjugate Dilution Source 
Rabbit Goat Alexa Fluor 555 1:1,000 Jackson ImmunoResearch 
Rabbit Goat IRDye 680 1:10,000 LI-COR Biosciences 
Rabbit Goat IRDye 800 1:10,000 LI-COR Biosciences 
 
2.5.2 Immunofluorescence cytochemistry 
Dissociated DRG neurons were grown on coverslips for 24-72 h, and fixed in 4 % 
paraformaldehyde for 20 min, followed by permeabilization with 0.1 % Triton X-100 in PBS at 
room temperature for 30 min. The cells were then blocked with 2 % goat serum, 2 % horse 
serum and 1 % BSA for 30 min, prior to incubation with primary antibodies overnight at 4 °C. 
Cells were then incubated with secondary antibodies for 1 h at room temperature. Coverslips 
were then mounted onto glass slides with an anti-fade reagent with DAPI (Prolong Gold; Life 
Technologies) and subject to fluorescence microscopic analysis. 
2.5.3 Immunofluorescence histochemistry 
Sections were blocked with SEA BLOCK blocking buffer (Thermo Scientific) for 1 h at 
room temperature. Tissues were incubated with primary antibodies overnight at 4 °C. Sections 
were then washed, incubated with secondary antibodies for 1 h at room temperature. Slides were 
coverslipped with anti-fade reagent (Prolong Gold; Life Technologies). 
2.5.4 Analysis and quantification of immunostaining signal 
Images were captured under identical parameters for control and experimental conditions 
also processed at the same time. Images were quantified for average fluorescence signal using 
Northern Eclipse software (Empix Imaging). 
2.5.5 Western blot analysis 
Proteins were extracted with RIPA buffer containing protease inhibitors cocktail. Twenty 
g of protein were electrophoresed on a SDS polyacrylamide gel, and then transferred onto a 
polyvinylidene fluoride membrane (Bio-rad). Membranes were blocked with blocking buffer 
(LI-COR Biosciences) at room temperature for 1 h. Membranes were then incubated with 
primary antibodies overnight at 4 °C, followed by incubation with secondary antibodies for 1 h 
at room temperature. Proteins were visualized by the Odyssey Infrared Imaging System (LI-COR 
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Biosciences). Lamin B was used as a loading control. For quantification, the density of each 
band on the immunoblot was estimated by densitometry and normalized to the density of the 
loading control band in the sample. 
2.5.6 Immunoprecipitation 
Antibodies were cross-linked to Dynabeads protein A (Invitrogen Dynal AS). Cell lysates 
were precleared with IgG Dynabeads protein A for 30 min at 4 °C before incubation with 
specific antibody-linked Dynabeads overnight at 4 °C. The immunoprecipitated Dynabead 
complexes were washed three times with RIPA buffer. Proteins were eluted by boiling in protein 
loading buffer prior to Western blot analysis. 
2.6 Statistical analyses 
All statistical analyses were performed with Prism (GraphPad Software). Differences 
between means were assessed by one-way analysis of variance (ANOVA) with post hoc Tukey's 
analysis. All values in the figures are expressed as means ± SEM (standard error of the mean) 
with differences in the mean values considered to be significant at p<0.05.  
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3 Results 
3.1 Cloning and characterization of rat Luman 
The coding sequences for the Luman gene have been reported for human (Lu et al., 1997), 
mouse (Burbelo and Kozak, 1998), and pig (Qi et al., 2009). But, when a previously reported rat 
sequence for Luman (GenBank: BC062241.1) was examined, I discovered that it was truncated, 
coding only a portion of the cytoplasmic domain. The truncated rat sequence lacked important 
functional domains including the nuclear localization signal, the bZIP domain that mediates 
DNA binding, the transmembrane domains and the ER luminal domain found in the mouse and 
human equivalents. I amplified by PCR the full Luman coding nucleotide sequence from 
transcripts from rat DRG tissue, cloned the sequence, and characterized its expression and 
distribution in a variety of rat tissues (Ying et al., 2014). 
3.1.1 Cloning of rat Luman cDNA 
Using a PCR-based approach I recovered cDNA for a putative transcript for Luman from 
rat DRG and determined its nucleotide sequence (Figure 3.1.1). The 1164 nucleotide sequence 
codes for a 387 amino acid protein, 233 amino acids longer than the predicted rat sequence in the 
Genbank database (GenBank: BC062241.1). The derived amino acid sequence contains a 
potential bipartite nuclear localization signal (NLS) and a basic leucine zipper (bZIP) region. 
When aligned to mouse Luman (NP_038525.2) and human Luman (NP_006359.3), rat Luman 
displays 85 % and 66 % amino acid identity, respectively (Figure 3.1.2). In addition, all of the 
important functional domains including the bipartite nuclear localization signal, leucine zipper 
region, HCF-binding domain and transmembrane domain are conserved with most of the amino 
acid substitutions being conservative. These data suggest that the cloned cDNA represents an 
orthologue of the mouse and human Luman. 
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Figure 3.1.1 cDNA and putative amino acid sequences of rat Luman 
The nucleotide sequence of the identified cDNA encodes a protein of 387 amino acids with a predicted molecular 
mass of 42.9 kDa. This sequence contains a predicted bipartite nuclear localization signal (underlined with basic 
amino acids shown in bold); a leucine zipper region (underlined with a dashed line with leucines shown in bold) 
with a tyrosine substitution at the second and an isoleucine substitution at the seventh leucine heptad positions; and 
the predicted transmembrane domain (underlined with a double line). 
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Figure 3.1.2 Amino acid sequence alignment of rat, mouse, and human Luman 
Amino acids in shaded boxes indicated by asterisks “*” represent fully conserved residues; colons “:” indicate 
conservation between groups of strongly similar properties, and periods “.” indicate conservation between groups of 
weakly similar properties. 
 
3.1.2 Rat Luman activates transcription from UPRE consensus sequences 
I next assessed whether the rat Luman sequence encodes a functional protein capable of 
activating transcription from the unfolded protein response element (UPRE) in a manner similar 
to human Luman (Liang et al., 2006). Luman constructs (pcLuman or pcRatLuman) or control 
plasmid and pCAT3BATF6, a CAT reporter plasmid with the coding sequences of CAT 
following five copies of the UPRE, were cotransfected into Vero cells. Figure 3.1.3A reveals that 
both human and rat Luman can activate the UPRE reporter and appear to drive similar levels of 
CAT expression (> 20 times above the control plasmid/background level). 
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3.1.3 Tissue distribution of rat Luman mRNA 
The relative levels of Luman transcripts were assessed in various tissues of the nervous 
system as well as other organs. RNA was extracted from cortex, cerebellum, hippocampus, DRG, 
sciatic nerve, liver, spleen, stomach, heart, lung, kidney, and intestine. Figure 3.1.3B shows high 
integrity and quality of isolated RNA. Luman transcript levels in these tissues, relative to 18S 
RNA, were assessed by qRT-PCR. 18S RNA was selected as the normalizer as its levels, in 
contrast to other “house-keeping” genes such as GAPDH and -actin, were consistent in the 
various tissues examined. Figure 3.1.3C shows that with the exception of liver, Luman RNA was 
more abundant in various nervous tissues (cortex, cerebellum, hippocampus, DRG and nerves) 
than in non-nervous tissue (spleen, lung, heart, kidney and intestine). 
 
Figure 3.1.3 Rat Luman activates transcription and its mRNA is widely expressed 
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(A) Human and rat Luman are equipotent at activating CAT reporter gene expression via the unfolded protein 
response element. pcDNA3.1, pcLuman or pcRatLuman was contransfected with CAT reporter plasmid 
pCAT3BATF6 into Vero cells. CAT protein level measured by ELISA, 24 h post-transfection. (B) Total RNA 
extracted from rat tissues was analyzed with Agilent bioanalyzer. A representative simulated electrophoresis gel is 
shown with the average RNA integrity number (RIN) shown at the bottom. (C) Mean (±SEM) levels of Luman 
mRNA relative to 18S rRNA levels from tissues as indicated. Note Luman mRNA is most highly expressed in 
nervous system tissues. N=3. 
 
I next localized Luman mRNA transcripts in DRG, hippocampus, and liver by in situ 
hybridization. Transcripts for Luman mRNA were detected in the cytoplasm of neurons and 
satellite glial cells in the DRG sections (Figure 3.1.4A, B) and in the cytoplasm of hepatocytes in 
liver sections (Figure 3.1.4C, D). The transcripts were mainly expressed in the pyramidal cell 
layer of CA1 and CA3, and the granular cell layer of the dentate gyrus in the hippocampal region 
in the brain (Figure 3.1.4E, F). The hybridization signal over the tissue was specific as it could 
be effectively competed away with an excess of cold probe (Figure 3.1.5). 
 
Figure 3.1.4 Luman mRNA localization in DRG, liver, and hippocampus 
Dark-field photomicrographs of rat DRG (A), liver (C) and hippocampus (E) sections processed for radioactive in 
situ hybridization to detect Luman mRNA. Brightfield photomicrographs of the same fields of rat DRG (B), liver (D) 
and insert box of hippocampus (E) reveals that all cells appear to have some basal level of Luman expression. (A 
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and B) DRG neurons are positive for Luman expression while arrows indicate representative satellite glial cells with 
positive hybridization signal. Scale bar: 50 m. (C and D) Hybridization signal localizes to hepatocyte cytoplasm. 
Scale bar: 50 m. (E and F) Luman mRNA transcripts in CA1-CA3 pyramidal cell layers and the granule cell layer 
of the dentate gyrus (DG). Region within the white box in E (Scale bar: 500 m) is shown at a higher magnification 
in F (Scale bar: 250 m). 
 
 
Figure 3.1.5 In situ hybridization specificity control for Luman probe 
Serial L4 DRG sections were hybridized with radio-labeled probe (35S-Luman), labeled probe with a 1000-fold 
excess of another dissimilar unlabeled probe (35S-Luman+1000X dissimilar probe), or radio-labeled probe with a 
1000-fold excess of unlabeled probe (35S-Luman+1000X Luman). Note: the excess dissimilar probe did not alter the 
hybridization signal pattern, while the excess unlabeled Luman probe effectively competed all specific binding 
leaving only background levels over tissue and non-tissue regions of the slide. Scale bar: 100 m; * indicates non-
tissue regions. 
 
3.2 Importin-mediated retrograde transport of Luman promotes neurite 
out growth in injured sensory neurons 
 A complex series of cellular and molecular events participate in reprogramming sensory 
neurons as they transition to a regenerating state following peripheral nerve injury (Lieberman, 
1974; Abe and Cavalli, 2008; Gumy et al., 2010; Ben-Yaakov et al., 2012). Injury discharge and 
rapid ion-fluxes initiate this transition, with loss of target-derived signals and receipt of 
retrograde signals from the site of injury following (Gunstream et al., 1995; Murphy et al., 1999; 
Michaelevski et al., 2010; Jung et al., 2012). These include injury-induced activation of intra-
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axonal transcription factors and their local synthesis (Lindwall and Kanje, 2005; Ben-Yaakov et 
al., 2012). Multiple axonal transcription factor transcripts have been identified in the injured 
nerve suggesting that many may serve as retrograde regeneration signals linking axonal injury to 
nuclear activities. However, only a role for axonal STAT3 in neuronal survival of injured 
sensory neurons has thus far been demostrated (Ben-Yaakov et al., 2012). 
Luman localizes to both the somal and axonal ER of DRG neurons and its transcript was 
previously identified, but not validated, in transcriptome analysis of injured sensory axons 
(Gumy et al., 2011). Based on the facts that Luman transcripts are highly expressed in DRGs and 
nerves (Figure 3.1.3) and that Luman contains the NLS sequence (Figure 3.1.1), I hypothesized 
that axonal Luman, as an ER-localized transcription factor, may serve to transduce injury stress 
signals from remote axonal locations back to the cell body. 
3.2.1 Luman mRNA localizes to adult sensory neuron axons 
Transcriptome analysis of adult sensory axons led to the identification of mRNA 
transcripts for several transcription factors including Luman (Gumy et al., 2011). To validate the 
axonal localization of Luman mRNA, the transwell culture insert approach for isolating axons 
and obtaining pure axonal isolates was employed (Figure 3.2.1A). Dissociated DRG neurons 
from naïve animals cultured on the top surface of membrane inserts can extend their neurites 
through the membrane pores, thereafter growing on the lower membrane surface. A pure axonal 
sample for analysis was obtained by carefully scraping away cultured cell components from 
either the top or bottom surfaces of the insert membrane. Immunofluorescence staining of the 
scraped membranes for the neuronal marker III tubulin coupled with nuclear DAPI staining 
(Figure 3.2.1B) revealed that all cell bodies could be removed from the upper surface of the 
membrane without peeling away axons extending to the lower membrane surface. To assess the 
purity of the lower membrane axonal preparations, protein extracts from the upper (cell bodies 
and proximal axons/neurites) and the lower (distal axons) surfaces of the membrane inserts were 
prepared and analysed by Western blot. The nuclear envelope protein Lamin B was detected only 
in upper membrane samples, while the microtubule protein -III tubulin was detected in samples 
from both sides of the membrane (Figure 3.2.1C), confirming the presence of axons and a lack of 
neuronal and nonneuronal cell bodies on the lower membrane surface. 
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To examine for the presence of axonal Luman mRNA, upper or lower membrane mRNAs 
were extracted and used for reverse transcription. RT-PCR revealed that both Luman and β-actin 
mRNAs could be amplified from the lower membrane axonal preparations, the latter being a 
confirmed axonal mRNA (Zheng et al., 2001). The purity of the axonal mRNA preparation was 
confirmed by the absence of a signal for -actin, a previously identified mRNA excluded from 
the axonal compartment, but present in the neuronal cell bodies (Figure 3.2.1D) (Zheng et al., 
2001). Taken together, these data indicate that Luman mRNA localizes to axons of DRG neurons. 
 
Figure 3.2.1 Luman mRNA is localized to axons 
(A) Schematic representation of transwell cell culture insert employed. Dissociated naïve DRG neurons are seeded 
on top of the porous membrane (3 m pores). Axons grow through the membrane pores such that distal axons are 
localized on the lower surface of the membrane. (B) DRG neurons plated onto a transwell insert 24 h prior to 
processing for immunofluorescence to detect -III tubulin (green) with DAPI-stained nuclei (blue). Lower 
membrane images acquired directly below the upper membrane focal plane reveal no detectable nuclear DAPI signal 
along the lower membrane surface. To isolate axons, the upper membrane was scraped, removing all cellular 
elements from the upper membrane surface, while axons that had traversed the membrane remain adhered to the 
lower surface of the membrane. Scale bars, 100 m. (C) Western blot analysis of proteins extracted from 
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neurite/axonal (Lower) and cell body and proximal axons (Upper) preparations of DRG neurons cultured for 24 h 
revealed no detectable nuclear envelope Lamin B protein in neurite/axonal (Lower) samples, while -III tubulin is 
detected in both compartments. (D) RNA extracted from neurite/axonal (Lower) and cell body (Upper) preparations 
from DRG neurons cultured as in (B) was analyzed by RT-PCR. No signal for the neuronal cell body restricted -
actin was detected in the axonal prep (Upper), but -actin and Luman mRNAs were both detected in the isolated 
axons (Lower). 
 
3.2.2 Luman in synthesized in axons in response to nerve injury 
The presence of Luman mRNA (Figure 3.2.1D) and protein synthesis machinery 
(Merianda et al., 2009) in axons support the hypothesis that Luman could be locally synthesized 
in injured axons. To examine this, L4, L5 and L6 DRG neurons were injury-conditioned with a 
sciatic nerve crush injury 24 h prior to being isolated and cultured on transwell inserts. After 48 h 
in culture, distal axons were severed from the cell bodies to exclude anterograde transport of cell 
body-synthesized Luman to the axon. Desomatized sensory axons remain metabolically active 
and capable of continued protein synthesis (Zheng et al., 2001). Thus, de novo Luman protein 
synthesis was assessed in desomatized axons by immunofluorescence microscopy, which 
revealed that axonal Luman protein levels increased in the absence of cell bodies over the 6 h 
period examined (Figure 3.2.2A and C). To confirm that the increased axonal Luman level 
represented newly synthesized protein, the isolated axons were treated with the protein synthesis 
inhibitor cycloheximide (10 g/mL) for the 6 h de novo protein synthesis period, which 
effectively inhibited the increase in axonal Luman (Figure 3.2.2A and C). 
Desomatization does not appear to serve as the signal regulating continued axonal Luman 
synthesis, as axonal Luman levels associated with naïve neurons do not increase following 
desomatization in vitro (Figure 3.2.2B and C). These data instead indicate that Luman is 
synthesized de novo in axons in response to molecular events triggered by pre-culture nerve 
injury. 
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Figure 3.2.2 Luman is locally translated in axons of pre-injured neurons 
(A) Dissociated 24 h injury-conditioned neuronal cultures from associated L4, 5, 6 DRG. After 48 h in vitro, upper 
membranes (cell bodies and proximal axons) were scraped, and the lower components (desomatized neurites) 
continued to be cultured ± 10 g/mL the translation inhibitor cycloheximide (CHX) for 6 h. Alterations in Luman 
protein levels were assessed by immunofluorescence (green) of axons identified with anti--III tubulin (red). Scale 
bars, 50 m. (B) Same experiments as in (A), but DRGs were not pre-injured. (C) Quantification of results in A and 
B. Application of CHX prevented the increase in Luman immunofluorescence normally observed in the desomatized 
injury-conditioned axons, demonstrating that the increase in Luman levels requires ongoing protein synthesis (mean 
± SEM; N = 40; **p<0.01). 
 
3.2.3 Luman is removed from axons in a proteasome-independent manner 
following nerve injury 
Luman is an ER-resident bZIP transcription factor that can be rapidly activated by 
regulated intramembrane proteolysis resulting in the translocation of the cleaved/activated N-
terminal cytoplasmic portion back to the nucleus (Lu and Misra, 2000; Raggo et al., 2002). In 
DRG cultures from naïve animals, I find Luman localizes to both neuronal somata and associated 
neurites. The neurite/axonal localization of Luman is largely restricted to punctae colocalizing 
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with the ER membrane marker calnexin (Figure 3.2.3A). This distribution pattern however, 
changes with peripheral nerve injury. The punctate axonal distribution of Luman observed in 
naïve neurons had largely disappeared in the 1 d injury-conditioned neurons (Figure 3.2.3B). To 
examine whether this was due to degradation of Luman protein, the experiments were repeated 
in the presence of the proteasome inhibitor MG-132, but this did not prevent the disappearance 
of axonal Luman in the injury-conditioned neurons (Figure 3.2.3B). Further, temporal Western 
blot analysis of in vivo nerve crush experiments revealed that the levels of cleaved/activated 
Luman gradually decreased over time in sciatic nerve protein samples from 10 mm segments just 
proximal to the crush site, but then correspondingly increased in samples from the L4, 5, 6 DRGs 
contributing to these injured nerves (Figure 3.2.3C). Together, this evidence suggests that the 
disappearance of axonal Luman is likely due to retrograde transport from axon to soma. But it is 
also plausible that the protein might have been degraded by a process not inhibited by MG-132. 
To assess whether Luman is removed from axons of injury-conditioned neurons by 
retrograde transport versus protein degradation and to eliminate the potential contributions of 
Schwann and satellite cell-derived Luman in interpretation of the results, the transwell insert 
culture approach was employed to obtain pure axonal isolates. Temporal analysis of alterations 
in Luman protein levels in isolated axon samples from injury-conditioned neurons cultured in the 
presence or the absence of the proteasome inhibitor MG-132 was performed and then compared 
to Luman axonal protein levels in cultures derived from naïve sensory neurons at the various 
time points examined (Figure 3.2.3D). Axonal Luman immunofluorescence signal detected on 
the lower membranes of injury-conditioned cultures ± proteasome inhibition revealed that 
proteasome inhibition did not alter the Luman levels detected in the injured axons at all time 
points examined. Luman levels in injured axons were always significantly less then levels from 
naïve neuronal cultures. By 2 DIV (3 d after in vivo injury) axonal Luman protein levels were 
maximally decreased to 25 % that of naïve axons/neurites at the same time point (Figure 3.2.3D). 
However, this change appeared transient as levels of Luman protein detected in the axons 
increased approaching that of the naïve culture levels by 3 DIV (4 d post sciatic nerve 
conditioning injury; Figure 3.2.3D). Because the reductions in axonal Luman levels in the injury-
conditioned cultures were not altered by proteasome inhibition, this indicates a proteasome-
independent pathway for Luman removal from axons, likely one of retrograde transport. It 
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should also be noted that the axonal Luman levels did not change significantly in the naïve group 
over the time course of the experiment (Figure 3.2.3). 
 
Figure 3.2.3 Luman localizes to the ER and is removed from DRG axons in a proteasome-independent 
manner in response to nerve injury 
(A) Dissociated naïve DRG neurons cultured for 24 h then processed for immunofluorescence to detect Luman (red) 
and the ER component Calnexin (green) with DAPI-stained nuclei (blue). Merged figure shows that Luman 
colocalizes with Calnexin and appears as discrete punctae along the axons/neurites. (B) Dissociated DRG neurons 
that were injury-conditioned for 24 h prior to culturing for 24 h, and processing for immunofluorescence to detect 
Luman (green) and -III tubulin (red) with nuclei visualized by DAPI staining (blue). Note: axon localized Luman 
has largely disappeared from the pre-injured axons relative to naïve control axons. This change is not inhibited by 
proteasome inhibitor MG-132 nor altered in the presence of its diluent DMSO. (C) Representative Western blot 
temporal analysis of proteins extracted from sciatic nerve injured DRGs and associated 10 mm segments of sciatic 
nerves just proximal to the injury site detect Luman at times post-injury as indicated, with Lamin B serving as the 
loading control. Levels of the cleaved/activated cytoplasmic N-terminal of Luman (lower bands) transiently increase 
then decrease in injured nerves, while gradually increasing in a reciprocal manner in DRGs, suggesting the gradual 
loss of Luman in the nerves is due to retrograde transport back to the neuronal cell bodies in the DRG. (D) Naïve or 
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24 h injury-conditioned DRG neurons were dissociated and seeded onto tissue culture inserts with or without MG-
132 and fixed at the time points indicated. Luman in axons were analyzed by assessing changes in the levels of 
axonal immunofluorescence (mean ± SEM; N=40) as normalized to naïve controls at 12 h culture time point. Note 
that the decrease in axonal Luman levels is transient and that at all time points examined there is significantly less 
Luman detected in both experimental groups as compared to naïve controls. The lack of a significant difference 
between crush and crush+MG-132 groups indicates that Luman disappears from axons via a proteasome-
independent pathway (*p<0.05; **p<0.01; ***p<0.001). Scale bars = 100 m. 
 
3.2.4 The importin system is activated by nerve injury 
Axonal proteins containing NLS are retrogradely transported to the soma and nucleus by 
importins (Hanz et al., 2003). To confirm the influence of nerve injury on the levels of importins 
in the sciatic nerve injury model, I analyzed the levels of importin  and importin . In protein 
samples derived from sciatic nerve segments proximal to injury, both importin  and importin  
are significantly increased after nerve injury (Figure 3.2.4A and B). Cellular alterations in the 
levels of importin  and Luman in DRG neurons were also examined on L4 DRG from naïve and 
sciatic nerve crushed rats. Figure 3.2.4C shows that the levels of Luman and importin  
increased only in the injury-conditioned neurons, with the most notable increase being observed 
in the nuclei where both markers co-localized. These data indicate that the importin system is 
activated by sciatic nerve crush injury in agreement with previous studies (Hanz et al., 2003) and 
provide anatomical evidence that Luman may be one of the cargo proteins. 
44 
 
 
Figure 3.2.4 Nerve injury activation of the importin system 
(A) Representative Western blot analysis of Importin  and in proteins extracted from 10 mm nerve segments just 
proximal to a 24 h sciatic nerve crush site with Lamin B as the loading control. (B) Quantification of results 
obtained in (A). Expression of Importin  and are significantly increased in response to nerve injury (mean ± SEM; 
*p< 0.05; **p<0.01; N=3). (C) L4 DRG sections from naïve or 24 h injury-conditioned animals processed for 
immunofluorescence to detect Importin (green), and Luman (red), reveal that 24 h after nerve injury, neuronal 
nuclei with increased Importin  staining (examples indicated with arrows) also show increased nuclear Luman 
signal, but there is no nuclear Luman detected in sections from naïve animals. Scale bar, 50 m. 
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3.2.5 Retrograde transport of Luman following nerve injury is mediated by 
importin  
The presence of a bipartite NLS in Luman (Figure 3.2.5A) identifies it as a potential 
cargo protein of importin . To determine the interaction between Luman and importin , 
immunoprecipitation experiments were performed using protein samples from L4, 5, 6 DRG 
neuronal cultures from naïve or injury-conditioned animals. Using anti-importin , importin  
and associated proteins were immunoprecipitated and the resulting samples were probed for 
Luman. A 40 kDa Luman band was immunoprecipitated along with importin  in samples from 
sciatic nerve injured animals, but not from naïve animals (Figure 3.2.5B). 40 kDa Luman is the 
expected size of the proteolysis cleaved/activated N-terminal cytoplasmic domain of Luman, 
which contains all its identified functional domains, including its activation domain, basic region 
and leucine zipper and has been shown to translocate to the nucleus (Lu et al., 1997; Lu et al., 
1998; Raggo et al., 2002); To determine whether the NLS is critical to the interaction between 
Luman and importin , I used a membrane-permeable peptide that contains the NLS sequence 
found within the NF-B p50 subunit (Lin et al., 1995) which has been shown to be able to block 
nuclear transport of NF-B, AP-1, NFAT and STAT1 (Torgerson et al., 1998) and also that of 
CREB2 (Lai et al., 2008) by antagonizing their interaction with importin . Incubation with 
excess NLS peptide significantly abolished the interaction between Luman and importin , 
compared with untreated cultures or with cultures incubated with peptides in which the NLS 
sequence was mutated (mNLS) so that it no longer binds to importin Figure. These 
findings support the hypothesis that Luman interacts with importin  via its NLS. 
 To more directly test whether the cleaved/activated cytoplasmic domain of Luman is 
retrogradely transported from axon to soma after nerve injury, I blocked the polymerization of 
microtubules which play a crucial role in retrograde transport of importin-associated cargo (Hanz 
et al., 2003). In the pure axonal samples, the reduction/disappearance of the cytoplasmic domain 
of Luman from the injury-conditioned axons was unaffected by addition of the proteasome 
inhibitor MG-132 and lysosome inhibitor chloroquine, indicating once again that this process 
occurs via a proteasome/protein degradation-independent pathway. However, application of 
colchicine, which inhibits the polymerization of microtubules prevented microtubule-dependent 
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transport of Luman and eliminated the normally observed reduction in axonally localized 
cleaved/cytoplasmic domain of Luman following nerve injury (Figure 3.2.5C and D). 
 
Figure 3.2.5 Importin-interacts with Luman in injured neurons 
(A) Schematic representation of the structure of Luman. NLS predicts site of interaction of Luman with importin 
(B) The interaction between Luman and importin  was analyzed by immunoprecipitation (IP) followed by 
Western blot. Association of the cleaved cytoplasmic domain of Luman (lower band) with importin is detected in 
rat DRG neurons subjected to a 24 h sciatic nerve injury, but not from naïve rats. The interaction is abolished in 
neurons treated with an NLS competitor peptide (Crush + NLS) but not in neurons treated with control mutant NLS 
(Crush + mNLS). Input lane represents control sample from injury-conditioned DRGs prior to IP. (C) 24 h injury-
conditioned DRG neurons were cultured for 48 h on tissue culture inserts in the presence or absence of MG-132 + 
chloroquine or colchicine, followed by isolation of axons and detection of axonal Luman levels by Western blot. 
Note that relative to naïve control, injury conditioned axons have less Luman, especially evident for the 
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cleaved/activated cytoplasmic domain form (lower band). This decrease is unaffected by inhibition of protein 
degradation (MG-132+chloroquine), but is prevented in the presence of the retrograde transport inhibitor colchicine. 
(D) Quantification of the Luman cleaved/activated cytoplasmic domain levels (lower band) observed in C (mean ± 
SEM; **p<0.01; N=3). Note: Axonal levels of cleaved Luman cytoplasmic domain decrease significantly after 
nerve injury with or without protein degradation inhibitors MG-132 and chloroquine, but this is prevented by 
colchicine inhibition of microtubule polymerization, implying that the removal of Luman from axons is a 
microtubule-dependent process. 
 
In response to cellular stressors, such as nerve injury in the present study, Luman is 
cleaved/activated by regulated intramembrane proteolysis releasing an N-terminal fragment for 
translocation back to the nucleus (Raggo et al., 2002) This fragment is visualized as the lower 
molecular weight form of Luman on Western blots (Figure 3.2.5B). To more precisely examine 
retrograde trafficking of the activated Luman N-terminal fragment, an adenoviral vector 
Ad/GFP-Lu-RFP was created in which a GFP tag was fused to the cytoplasmic N-terminus that 
contains all the functional domains of the protein, while a RFP tag was fused to the C-terminus 
of rat Luman which remains bound to the membrane. Ad/GFP-Lu-RFP enabled sufficient 
expression of GFP-Luman-RFP fusion protein in cultured DRG neurons (Figure 3.2.6A). In 
infected neurons the addition of these tags did not appear to alter the localization of this protein 
nor it functional properties. The GFP-Luman-RFP fusion protein activated transcription from the 
UPRE in a manner similar to wild type Luman (Figure 3.2.6B), and it localized to the ER in both 
the cell bodies and neurites/axons (Figure 3.2.6C and D) consistent with that observed for wild 
type Luman (Figure 3.2.3A). 
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Figure 3.2.6 Ad/GFP-Lu-RFP delivers functional GFP-Luman-RFP into neurons that localizes to the ER 
(A) DRG neuron cultures were infected with Ad/GFP-Lu-RFP at a MOI of 100 and neurons were visualized by  III 
tubulin immunostaining (blue). Scale bar: 100 m. (B) Luman (pcRatLuman) and GFP-Luman-RFP fusion protein 
(pcGFP-Lu-RFP) can activate CAT reporter gene expression but the control plasmid does not (pcDNA3.1). (C and 
D) DRG sections from animals infected in vivo (C) and in vitro (D). Colocalization of GFP-Luman-RFP fusion 
protein and ER protein GRP-78. Merged images reveal that GFP-Luman-RFP fusion protein localizes to the ER both 
in vivo and in vitro. Scale bar: 50 m. 
 
Exposure of dissociated DRG cultures to this construct at 100 MOI for 48 h was 
sufficient to transduce the neurons such that both RFP and GFP tags were visible and perfectly 
colocalized in the soma and neurites (Figure 3.2.7A, 0 h). To investigate whether axonal injury 
results in Luman cleavage/activation and translocation to the nucleus in vitro, an axonal scratch 
injury was made with a pin rake, and neurites immediately adjacent (proximal) to the injury site 
and their cell bodies were imaged with time-lapse microscopy for 24 h. The injury resulted in the 
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disappearance of GFP from the distal most tips of axons just proximal to the injury site and a 
corresponding accumulation of GFP in the nucleus, with no discernible change in the distribution 
of RFP (Figure 3.2.7A, C, and D). This is consistent with the cleavage/activation of the N-
terminal cytoplasmic portion of Luman while the C-terminus remains membrane bound. The 
disappearance of GFP in the axon and the accumulation of GFP in the nucleus was significantly 
blocked by a competitor NLS peptide, suggesting importin-dependent transport of GFP-Luman 
from the axon (Figure 3.2.7B, C, and D). 
 
Figure 3.2.7 in vitro retrograde transport of GFP/RFP dual tagged Luman 
(A) Dissociated DRG cultures were infected Ad/GFP-Lu-RFP for 48 h. An in vitro scratch injury was made at 0 h 
and a temporal analysis of alterations in disappearance of the cleaved/activated GFP-tagged N-terminus (green) was 
monitored at the 5 time points indicated. Note that the RFP-tagged C terminus of Luman (red) remains unchanged 
and presumably membrane associated. Movement of GFP-tagged cleaved/activated N-terminal fragment of Luman 
was analyzed in the axon and cell body at the times indicated in the figure. Arrowheads indicate the injury site and 
arrows indicate the retrograde transport direction. Scale bar axon: 50 m, scale bar cell body: 20 m. (B) Same 
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experiments as in (A), but NLS peptide was added 24 h before the in vitro injury. Note the greatly diminished loss of 
Luman N-terminus GFP from the axon tip just proximal to the nerve injury site even 24 h post-lesion. Scale bar 
axon: 50 m, scale bar cell body: 20 m. (C) Quantification of the intensity of axonal GFP and RFP in (A) and 
axonal GFP in (B). (D) Quantification of the intensity of nuclear GFP and RFP in (A) and nuclear GFP in (B). The 
relatively stable levels of RFP, decreased levels of GFP in the axon and increased levels of GFP in the nuclei 
support that the N terminus of Luman (fused with GFP) is retrogradely transported from axons to nuclei after axonal 
injury, and this is inhibited in NLS-treated neurons. (N=10). 
 
To determine if retrograde transport of Luman also occurs in vivo, the sciatic nerve was 
crush injured for 24 h and then ligated proximal to the injury site for another 24 h followed by 
processing for Luman immunohistochemistry. The presence of intense immunostaining (Figure 
3.2.8A) distal to the ligation site is consistent with Luman being in transit in a retrograde 
direction from the initial crush injury site, as is the decrease in signal observed in the portion of 
the nerve proximal to the ligation. The intense Luman staining was only observed in the crush 
and ligated nerves, but not ligation only nerves, suggesting that retrograde transport from the 
initial crush injury site is activated by injury. 
The Ad/GFP-Lu/RFP was also used to track the movement of cleaved/activated Luman in 
vivo. Ad/GFP-Lu-RFP was injected intrathecally at the L5 DRG level and left for 7 d. Intrathecal 
injection has been shown to result in higher neuronal transduction efficiency than sciatic nerve 
injection (Towne et al., 2009). Expression of the viral construct in both DRGs and sciatic nerve 
was confirmed in sections from 7 d infected rats (Figure 3.2.6C and 3.2.8C). The right sciatic 
nerve was then crushed, and right and left sciatic nerves and L5 DRGs were dissected 48 h after 
the injury. In the intact nerve and DRG, GFP and RFP colocalized, and were not found in the 
neuronal nuclei (Figure 3.2.8C). On the injured side, the marked loss of GFP, but not RFP in the 
nerve proximal to injury and the accumulation of GFP in the nuclei of the DRG (Figure 3.2.8B) 
confirms that the N terminus of Luman was retrogradely transported to the nuclei after nerve 
injury in vivo. 
Together, the data indicate that the injury-associated loss of Luman from axons is due to 
importin-mediated retrograde transport back to the nucleus. 
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Figure 3.2.8 in vivo retrograde transport of Luman after nerve injury 
(A) Upper panel, sciatic nerve was ligated at mid-thigh level for 24 h (Ligation). Lower panel, sciatic nerve was 
crush injured for 24 h, then ligated proximal to the injury site for an additional 24 h (Crush + Ligation). The 
distribution of endogenous Luman was visualized by immunohistochemistry. An accumulation of Luman on the 
distal side of the ligation is most evident in the crush + ligation nerve (arrows) consistent with retrograde transport 
from the initial crush injury site. There is also a paucity of staining on the proximal side of the ligation, also 
consistent with retrograde transport centrally from ligation site. Scale bar, 50 m. N=3. (B and C) Ad/GFP-Lu-RFP 
was intrathecally injected at the L5 DRG level and left for 7 d prior to unilateral 48 h crush injury of the sciatic 
52 
 
nerve. Nerve sections were taken 1 mm proximal to injury site with the retrograde transport direction indicated by 
black arrows. Sections of injured (B) and intact (C) sciatic nerves and corresponding L5 DRGs were prepared. The 
localization of GFP (fused to the N terminus of Luman) and RFP (fused to the C terminus of Luman) were analyzed. 
GFP and RFP are colocalized in the uninjured nerves, and are not observed in the uninjured DRG nuclei (C). The 
cleavage/activation and apparent retrograde transport of the N terminus of Luman (GFP) after nerve injury results in 
reduced colocalization of GFP and RFP in the injured nerve most evident in the region of nerve closest to the injury 
site (B, arrows, nerve), and examples of the appearance of GFP in the nuclei of injured sensory neurons are shown 
(B, arrows, DRG). Scale bars: 100 m (nerve); 50 m (DRG). N=4. 
 
3.2.6 Axonal knockdown of Luman inhibits axonal outgrowth in injury-
conditioned DRG neurons 
Luman has been shown to participate in regulation of cell migration of osteogenic 
sarcoma cells that involves intricate cytoskeletal rearrangements (Ko et al., 2004). Because of 
this I speculated that axonal injury-activated Luman may serve to promote axon outgrowth in 
injured sensory neurons. Thus, I analyzed the neurite outgrowth of cultured DRG neurons where 
Luman expression was knocked down by transfecting the cultures with Luman selective siRNA. 
siRNA can be efficiently transfected into cultured DRG neurons (Figure 3.2.9A), and Luman 
siRNA transfection significantly decreased the Luman expression at both the mRNA (Figure 
3.2.9B) and protein (Figure 3.2.9C and D) levels. 
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Figure 3.2.9 Luman siRNA knocks down Luman expression in DRG neurons 
(A) Transfection efficiency test of siRNA. DRG neurons were transfected at a final concentration of 10 nM with the 
TYE 563 DS Transfection Control duplex, and imaged 24 h post-transfection (Red: labelled siRNA; blue: nuclei). 
Most cells can be transfected with labelled siRNA. (B) The mRNA levels of Luman in neurons cultured in 
experimental conditions as indicated. (C) Expression level of Luman was analyzed by Western blot from protein 
samples of cultured DRG neurons transfected with control nontargeting siRNA (Control siRNA) or rat Luman-
specific siRNA (Luman siRNA) 48 h previously. A representative blot is shown. (D) Quantification of Luman levels 
detected in Western blots from 3 separate experiments as in (C). Note: Luman siRNA significantly decreases the 
level of Luman detected (**p<0.01). 
 
DRG neurons cultured from 24 h sciatic nerve injury-conditioned or naïve rats were 
transfected with control siRNA or Luman siRNA. Forty-eight h after transfection, neurites were 
visualized by -III tubulin immunostaining. Total neurite outgrowth and branching were 
analyzed with representative neurons shown in Figure 3.2.10A. Injury-conditioned DRG neurons 
have longer and less branched neurites relative to naïve neurons. While knockdown of Luman 
significantly decreased the total neurite length of the pre-injured DRG neurons, it had no 
discernible impact on branching and had no effect on either parameter for the naïve neurons 
(Figure 3.2.10B and C). 
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Figure 3.2.10 Knockdown of Luman inhibits axonal outgrowth in pre-injured DRG neurons. 
(A) Naïve DRG neurons or 24 h injury-conditioned neurons (Crush) were assayed in vitro for 48 h in the presence of 
medium alone (Control), or transfected with nontargeting siRNA (Control siRNA) or Luman selective siRNA 
(Luman siRNA) for 48 h followed by -III tubulin (green) immunofluorescence. Note that pre-injured DRG neurons 
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have longer but less branched neurites as compared to naïve controls with substantially less neurite outgrowth in 
cultures transfected with Luman siRNA. Scale bar, 200 m. (B) Quantification of total neurite length in A (mean ± 
SEM; **p<0.01; ***p<0.001; N=250). Luman siRNA treatment significantly impaired axonal outgrowth from 
injury-conditioned neurons, but did not discernibly impact the outgrowth of DRG neurons from naïve rats. (C) 
Quantification of axon branches/neuron in A (mean ± SEM; ***p<0.001; N=50). The number of axon branches (end 
points/neuron) is significantly decreased after sciatic nerve injury, but knockdown of Luman did not impact the 
number of axon branches in either injury conditioned or naïve neurons. 
 
To better mimic the in vivo situation in vitro, and to more selectively knockdown axonal 
Luman expression, I cultured injury-conditioned DRG mini explants in compartmented 
chambers. The DRG explant cultures preserve relationships among neurons, Schwann cells and 
satellite glial cells that are lost in dissociated cultures. These cell relationships may play an 
important role in sensory neuron regeneration in vivo (Allodi et al., 2012; Zochodne, 2012). 
Compartmented culture allows selective application of Luman siRNA only to the distal axonal 
compartment (Figure 3.2.11A). Compartmented inserts formed three sealed compartments. 
Brilliant Blue G dye added to the central compartment showed no diffusion underneath the 
barrier (Figure 3.2.11B), and retrograde tracers applied to the side compartments labelled 
neurons with neurites extending to the corresponding compartments (Figure 3.2.11C). Axonal 
specific Luman knockdown was shown in figure 3.2.11 D and E, where only the region of 
neurites exposed to the siRNA were transfected (Figure 3.2.11D), and the expression of Luman 
was impacted only in the compartment exposed to the Luman siRNA (Figure 3.2.11E). 
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Figure 3.2.11 Axon-specific Luman knockdown 
(A) Schematic representation of compartmented cell culture dishes created by scratching the surface with a pin rake 
and placing a compartmented insert cut from 1 mm silicon on top of the scratches 1 d after DRG explants are seeded 
in the middle chamber. Axons from DRG explants grow under the silicon barrier, but all neuronal and noneuronal 
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cells are prevented from entering the axon compartments. (B) Solutions are compartmentally restricted, with 
Brilliant Blue G added to the central compartment and external to the compartments showing virtually no diffusion 
underneath the barrier over 24 h. (C) Section of a DRG explant whose neurites extended to the left and right 
compartments were treated with fluorogold (blue) and fluororuby (red), respectively. (D) Representative 
fluorescence photomicrograph montages of axonal outgrowth detected with -III tubulin immunofluorescence 
(green) from DRG explants. Explant compartment and silicon barrier regions (grey) are indicated. Right axon 
compartments were transfected with TYE 563 DS Transfection Control duplex (red). (E) Representative 
fluorescence photomicrograph montages of axonal outgrowth detected with -III tubulin immunofluorescence 
(green) and Luman immunofluorescence (red) from DRG explants. Explant compartment and silicon barrier regions 
(grey) are indicated. Left axon compartments were transfected with negative control nontargeting siRNA, while 
right axon compartments were transfected with Luman siRNA. Scale bar, 1 mm. 
 
Injury-conditioned DRG explants were transfected with control siRNA in the left axon 
compartment and rat Luman selective siRNA in the right axon compartment (Figure 3.2.12A). 
Control cultures compare culture medium alone in the right compartment to control siRNA in the 
left (Figure 3.2.12B). Seven days after the transfection, cultures were fixed and neurites were 
visualized with anti--III tubulin. The length of the 10 longest neurites/explant (left and right 
compartments) were measured with representative cultures shown in Figure 3.2.12A and B. 
Neurites/axons grown under normal culture conditions (Figure 3.2.12B right chamber) and 
control siRNA conditions (Figure 3.2.12A and B left chambers) are longer than axons 
transfected with Luman siRNA (Figure 3.2.12A, right chamber). Axonal knockdown of Luman 
significantly decreased the neurite length of injured DRG explants (Figure 3.2.12C). Collectively, 
these data support the hypothesis that axonal Luman translation is required for optimal neurite 
outgrowth after peripheral nerve injury. 
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Figure 3.2.12 Subcellular axonal knockdown of Luman inhibits axonal outgrowth in injury-conditioned DRG 
neurons. 
(A) Representative fluorescence photomicrograph montages of axonal outgrowth detected with -III tubulin 
immunofluorescence (green) from L4, 5, 6 DRG explants that were 24 h sciatic nerve injury-conditioned prior to 
culturing. Explant compartment and silicon barrier regions (grey) are indicated. Left axon compartments were 
transfected with negative control nontargeting siRNA, while right axon compartments were transfected with Luman 
siRNA for 7 d. Note: axon outgrowth is significantly shorter for axons treated with Luman siRNA as compared to 
those in the nontargeting control siRNA compartment. (B) Montages showing outgrowth from explants as in (A) but 
cultured under control conditions: normal medium (right compartment) or transfected with negative control 
nontargeting siRNA (left compartment) for 7 days with no discernible difference observed between control 
treatments. Scale bar, 1 mm. (C) Quantification of the 10 longest neurite/axon lengths from each DRG explant into 
right and left compartments; N = 60 (normal medium); 130 (control siRNA) or 70 (Luman siRNA) neurites/axons 
measured in A and B (mean ± SEM; ***p<0.001). Note: Knockdown of Luman in the axon compartment 
significantly decreased the length of neurites/axons from injury-conditioned DRG explants. 
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3.3 The UPR is a major mechanism by which Luman regulates injury-
induced neurite outgrowth 
During regenerative axon growth in the PNS complex pathophysiologic changes, 
including increased synthesis of RNA, protein, and lipids, occur at the levels of the injured axon 
and the cell body (Flores et al., 2000). The increased protein synthesis in the axon (Jung et al., 
2012) and the cell body (Burnett and Zager, 2004) plays a crucial role in nerve regeneration. 
Normally the accumulation of misfolded and unfolded proteins during protein synthesis triggers 
the UPR. The activation of UPR has been observed in many neurodegenerative diseases (Doyle 
et al., 2011). It is also involved in axon injury-induced retinal ganglion cell death (Hu et al., 2012) 
and Schwann cell survival after injury (Mantuano et al., 2011), but little is known about the 
function of UPR in regulating peripheral nerve regeneration. Thus, I decided to assess the UPR 
in axotomized DRG neurons and study the role of UPR in regulating PNS regeneration. 
3.3.1 Sciatic nerve crush injury triggers the UPR in DRGs 
To determine whether the increased protein synthesis during nerve regeneration induces 
the UPR in sensory neurons, I tested the levels of expression of several UPR-related genes in 
DRGs after sciatic nerve crush injury. ER resident chaperone GRP78 is expressed early in the 
UPR, as the dissociation of GRP78 and ER stress transducers activates the UPR pathways (Ron 
and Walter, 2007). CHOP, which has generally been used as an UPR marker (Samali et al., 
2010), was found to be up-regulated by optic nerve injury (Hu et al., 2012). Through the use of 
the mRNA isolated from DRGs, quantitative real-time PCR (qRT-PCR) analysis showed 
increased expression of GRP78 mRNA and CHOP mRNA in axotomized DRGs (Figure 3.3.1A), 
which was further confirmed by both in situ hybridization and immunohistochemical analysis in 
L4 DRG sections (Figure 3.3.1B and C). PERK and IRE1, the transducers of UPR (Cox et al., 
1993; Harding et al., 2000), Calnexin, a chaperone protein characterized by assisting protein 
folding and quality control (Ou et al., 1993), and protein disulfide isomerase (PDI), an enzyme 
that catalyzes disulfide formation and protein folding (Wilkinson and Gilbert, 2004) were also 
increased by axotomy in DRGs (Figure 3.3.1D). XBP-1 splicing has been considered as another 
marker of the UPR (Calfon et al., 2002). I examined whether the splicing product of XBP-1 
could be detected in DRGs after sciatic nerve injury. qRT-PCR showed significant increased 
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spliced XBP-1in the DRGs obtained one day after sciatic nerve crush injury (Figure 3.3.1A). 
These results demosntrate that 1 d sciatic nerve injury triggers the UPR in axotomized DRGs. 
 
 
Figure 3.3.1 One day sciatic nerve crush injury induces the UPR in adult DRG 
(A) Relative changes in mRNA levels of GRP78, CHOP, unspliced Xbp-1, and spliced Xbp-1 in DRGs from naïve 
and 1 d sciatic nerve crush injury animals normalized to naïve controls (means ± SEM; N=6; * p<0.01). (B) In situ 
hybridization shows the expression of GRP78 and CHOP in the L4 DRG under conditions as indicated. Scale bar, 
100 m. (C) Immunohistochemical analysis of GRP78 and CHOP immunoreactivity in DRG sections from 
experimental conditions as indicated. Scale bar, 100 m. (D) Immunoblot analysis of DRG protein samples from 
experimental conditions as indicated. Lamin B was employed as a loading control. CL, contralateral uninjured DRG. 
Note: All the UPR markers examined have increased levels of mRNA and protein expression in response to injury 
relative to the naïve state. 
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3.3.2 Luman is activated in response to sciatic nerve crush injury 
The induction of the UPR in DRG in response to sciatic nerve crush injury and the ability 
of Luman to regulate aspects of the UPR in other cell types, made me speculate that Luman 
likely regulates the peripheral nerve injury-associated UPR. To examine this, I first verified that 
the sciatic nerve crush injury model employed in these UPR studies induced expression and 
activation of Luman in the DRG. qRT-PCR analysis showed increased expression of Luman in 1 
d axotomized DRGs (Figure 3.3.2A), further confirmed by both Western blot and 
immunohistochemical analysis (Figure 3.3.2B and C). Luman is activated by regulated 
intramembrane proteolysis, which results in the amino-terminal portion of Luman being released 
from the ER and entering the nucleus to serve as a transcription factor (Raggo et al., 2002). 
Figure 3.3.2B shows that the crush injury not only increased the level of full length Luman, but 
also increased cleaved/activated Luman. Nuclear localization of Luman was also observed in the 
axotomized DRGs (Figure 3.3.2C). Therefore, these results indicate that Luman is activated and 
its expression is elevated in response to 1 d sciatic nerve crush injury. 
 
Figure 3.3.2 Sciatic nerve injury activates Luman in DRG 
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 (A) Quantification of expression of Luman mRNA in DRG detected by qRT-PCR. 18 S rRNA was used as the 
endogenous control (means ± SEM; N=6; * p<0.01). (B) Immunoblot analysis of DRG protein samples from 
experimental conditions as indicated. Upper band, full-length Luman (fl); lower band, cleaved Luman (cl). Lamin B 
was employed as a loading control. CL, contralateral uninjured DRG. (C) Immunohistochemical analysis of Luman 
immunoreactivity in DRG sections from experimental conditions as indicated. Nuclear localization of Luman is 
indicated by arrows. Scale bar, 100 m. Note: The mRNA and protein (both full-length and the cleaved/activated 
forms) levels of Luman increased in response to sciatic nerve injury. 
 
3.3.3 Knockdown of Luman decreases the injury-induced UPR 
To study the role of Luman in regulating the sciatic nerve injury-triggered UPR, I used 
qRT-PCR arrays designed to assess expression of genes related to the UPR to determine if 
knockdown of endogenous Luman altered the response. I compared RNA purified from 
dissociated 1 d injury-conditioned DRG neurons transfected with Luman-specific siRNA, or 
nontargeting control siRNA, for an additional 2 d. Figure 3.3.3A reveals that many UPR-related 
genes are down-regulated in the Luman knockdown neurons. To confirm these results I designed 
primers to amplify the genes that were down-regulated more than twofold, as well as GRP78, 
CHOP, XBP1, and spliced XPB1. qRT-PCR using these primers confirmed the results of the 
array (Figure 3.3.3B and C). Among the eight genes that were down-regulated more than twofold, 
Insig1, Insig2, Srebf1, and Mbtps2 are known to be involved in the regulation of cholesterol. 
Ubxn4 promotes ER-associated protein degradation and Canx facilitates protein folding and 
quality control. 
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Figure 3.3.3 Knockdown of neuronal Luman decreases the injury-induced UPR 
(A) Volcano plots from data derived from qRT-PCR arrays designed to monitor transcripts of genes associated with 
the UPR. The horizontal axis represents log2 fold differences between 1 d injury-conditioned DRG neurons 
transfected with scrambled non-targeting siRNA and Luman- specific siRNA. The vertical axis represents P values. 
The horizontal dashed line represents a P value of 0.05. Transcripts that were down-regulated more than 2-fold 
(vertical lines) and had a P value <0.05 were considered significant and are indicated by solid spots with gene 
designations. (B) A comparison of data from the qRT-PCR array with data from qRT-PCR experiments using 
primers designed in-house. Insig1 - insulin-induced gene 1, Srebf1 - Sterol regulatory element-binding transcription 
factor 1, Ubxn4 - UBX domain-containing protein 4, Insig2 - insulin-induced gene 2, Canx - Calnexin, Mbtp2 - 
Membrane-bound transcription factor site-2 protease. (C) Relative changes in mRNA levels of spliced Xbp-1, 
unspliced Xbp-1, CHOP and GRP78 in injury-conditioned DRG neurons transfected with scrambled siRNA and 
Luman-specific siRNA. Means ± SEM; N=6; * p<0.01. 
 
3.3.4 Rescue of axon/neurite outgrowth in Luman knockdown neurons by 
supplemented cholesterol in vitro 
The qRT-PCR results revealed that 4 genes involved in the regulation of cholesterol were 
down-regulated after Luman knockdown (Figure 3.3.3). Because cholesterol is an essential 
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structural component of cell membranes, I speculated that the Luman knockdown neurons were 
not making enough cholesterol to support the regenerative membrane growth induced by the 1 d 
sciatic nerve crush injury. Figure 3.3.4A shows that free and total cholesterol levels in injury-
conditioned sensory neurons were significantly decreased by 34 ± 7 % and 33 ± 5 %, 
respectively after Luman knockdown. To investigate whether the decreased cholesterol levels 
were causally linked to the shortened neurite outgrowth observed in response to Luman siRNA, 
Luman knockdown neurons from injury-conditioned DRGs were analysed in vitro in the 
presence and absence of cholesterol supplementation. In the absence of supplemented cholesterol, 
Luman knockdown neurons formed axons/neurites that were 48 ± 6 % shorter. Cholesterol 
supplementation had only a minor impact on control siRNA transfected neurons, but was 
significantly effective in the Luman siRNA treated neurons partially rescuing their intrinsic 
ability to extend axons/neurites such that they were now 74 ± 9 % that of control neurons after 2 
DIV (Figure 3.3.4B and C). These data also suggest that 1 d axotomized DRG neurons must 
produce all the cholesterol required for the extension of axons/neurites, as cholesterol 
supplementation did not increase total axon/neurite length (Figure 3.3.4 B and C). In Luman 
knockdown neurons, the lower levels of endogenous cholesterol production are apparently not 
sufficient to support the increased membrane growth caused by axotomy, which can be partially 
rescued by cholesterol supplementation. 
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Figure 3.3.4 Cholesterol dependency of neurite outgrowth 
(A) Cholesterol levels in cultured DRG neurons transfected with scrambled siRNA and Luman-specific siRNA. 
Knockdown of Luman decreased the free and total cholesterol levels (N=4). (B) Representative 24 h injury-
conditioned DRG neurons (Crush) assayed in vitro for 48 h in the presence of medium alone (Crush), transfected 
with control siRNA and 2 g/mL cholesterol (Crush + NC Si + Chol), transfected with Luman-specific siRNA 
(Crush + Luman Si), or transfected with Luman-specific siRNA and 2 g/mL cholesterol (Crush + Luman Si + Chol) 
followed by neurite detection with -III tubulin immunofluorescence. Scale bar, 200 m. (C) Quantification of total 
neurite length in B (N=150). Knockdown of Luman decreased the neurite outgrowth. Cholesterol supplementation 
partially rescued the neurite outgrowth in Luman knockdown neurons, but did not impact the pre-injured neurons. 
Means ± SEM; * p<0.01. 
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3.3.5 Rescue of axon/neurite outgrowth in Luman knockdown neurons by a UPR 
inducer 
Because cholesterol supplementation does not fully rescue the axon/neurite outgrowth 
reduction caused by Luman siRNA treatment (Figure 3.3.4), I next investigated whether other 
UPR-related genes down-regulated by Luman knockdown (Figure 3.3.3) may also contribute to 
the observed shortened axon/neurite outgrowth in a manner independent of cholesterol. Thus, 
tunicamycin, a UPR inducer previously shown to not activate Luman (Liang et al., 2006), was 
employed to increase the UPR level. Luman knockdown decreased Canx, Ubxn4, GRP78, CHOP, 
XBP1, and spliced XBP1 levels by 1.6 ± 0.25 fold to 4.2 ± 1.5 fold. In an attempt to increase 
those genes back to their normal injury-associated levels, different concentrations of tunicamycin 
were tested to determine whether any of them increased levels of the UPR markers in the Luman 
knockdown neurons, without an impact on the reduced levels of Luman or cholesterol. Figure 
3.3.5A shows that when tunicamycin was used at 2 ng/mL, the levels of the aforementioned 
UPR-associated genes were increased by 1.4 ± 0.5 fold to 3.1 ± 0.4 fold. Notably, this 
concentration did not have a discernible influence on the levels of Luman or cholesterol (Figure 
3.3.5B and C). I then analyzed axon/neurite outgrowth in Luman knockdown neurons from 
axotomized DRGs in vitro in the presence and absence of 2 ng/mL tunicamycin. While 
tunicamycin treatment had only minor impact on control siRNA transfected neurons, it partially 
rescued the axon length in Luman knockdown neurons after 2 DIV such that it was now 69 ± 9 % 
of that observed in control injury-conditioned neurons (Figure 3.3.5D and E). 
The Luman knockdown dependent decrease in axon/neurite outgrowth was partially 
rescued when cholesterol and tunicamycin were used alone. Since tunicamycin treatment did not 
alter the level of cholesterol (Figure 3.3.5C), cholesterol and tunicamycin may play different 
roles in the regulation of neurite outgrowth in axotomized DRG neurons. Figure 3.3.5E shows 
that when cholesterol and tunicamycin were used together, the axons/neurites grew significantly 
longer than that of when they were used individually, reaching 83 ± 10 % of that of control 
injury-conditioned only neurons. 
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Figure 3.3.5 Tunicamycin rescues axon/neurite outgrowth in Luman knockdown neurons 
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(A) mRNA levels of Canx, Ubxn4, XBP1, spliced XBP1, CHOP, and GRP78 in DRG neurons cultured in indicated 
concentration of tunicamycin. (B) mRNA levels of Luman in DRG neurons cultured in experimental conditions as 
indicated. (C) Free and total cholesterol levels in DRG neurons cultured in the absence or presence of 2 ng/mL 
tunicamycin (N=4). (D) Representative 24 h injury-conditioned DRG neurons (Crush) assayed in vitro for 48 h in 
the presence of medium alone (Crush), or transfected with either control siRNA and 2 ng/mL tunicamycin (Crush + 
NC Si + Tu), Luman-specific siRNA (Crush + Luman Si), or Luman-specific siRNA and 2 ng/mL tunicamycin 
(Crush + Luman Si + Tu) followed by axon/neurite detection with -III tubulin immunofluorescence. Scale bar, 200 
m. (E) Quantification of total axon/neurite length in D, as well as 24 h injury-conditioned DRG neurons cultured in 
the presence of Luman-specific siRNA, tunicamycin and cholesterol for 48 h (Luman Si + Tu + Chol). (N=150). 
Note: tunicamycin treatment partially rescued the decrease in neurite outgrowth in Luman knockdown neurons, but 
did not impact the pre-injured neurons. Means ± SEM; * p<0.05, ** p<0.01. 
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4 Discussion 
Luman is an ER-localized bZIP transcription factor that has been reported to regulate the 
UPR, cell migration, dendritic cell maturation, and secretory capacity. In this study, I cloned the 
rat Luman coding sequence and analyzed its expression and distribution in a variety of rat tissues. 
I further showed that, in response to peripheral nerve injury, Luman serves as an important 
axonally-derived retrograde injury signal that serves to regulate axon/neurite outgrowth through 
its regulation of the UPR pathway and cholesterol biosynthesis. 
4.1 Luman is highly expressed in nervous system 
Section 3.1 describes the isolation of a full-length coding sequence and the derivation of 
the predicted amino acid sequence for rat Luman. This rat sequence is comprised of 387 amino 
acids (Figure 3.1.1), 233 amino acid residues longer than the rat Luman sequence currently 
reported in the Genbank database (GenBank: BC062241.1). This latter sequence corresponds to 
only 154 amino acids of the amino-terminus of the protein. The rat Luman isolated in this study, 
when aligned to derived mouse and human amino acid sequences for Luman displays 85 % and 
66 % identity, respectively (Figure 3.1.2). Further, unlike the currently reported sequence, this 
new sequence has all of the known functional domains conserved, and encodes a protein capable 
of activating transcription from the UPRE in a manner equivalent to human Luman (Figure 
3.3.3A). 
Luman is distinguished from other members of the CREB family as being a member of a 
subfamily of membrane-associated bZIP transcription factors that in mammals includes CREB3 
and CREBL1-L4 [reviewed in (Chan et al., 2011)]. Another feature of this CREB subfamily is 
that these transcription factors are activated by regulated intramembrane proteolysis, which 
liberates the N-terminal active fragment from the membrane, thereby allowing it to translocate to 
the nucleus where it has been shown to modulate transcriptional activity. But, the exact nature of 
the physiological signals that mediate activation of Luman in vivo remain elusive. 
The broad expression of rat Luman that I found across all tissues examined, is consistent 
with that reported for human Luman (Lu et al., 1997) and implicates it in potentially diverse or 
alternatively, common cellular physiological functions. The highest levels of expression occurred 
in liver and nervous system tissue. In the liver, transcripts were found in the cytoplasm of 
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hepatocytes. It is well known that hepatocytes are rich in endoplasmic reticulum (ER), which is 
the site of the synthesis and modification of a large number of secreted proteins. This high level 
of secretory function makes the liver particularly susceptible to ER stress (Ji et al., 2011), where 
Luman may play a role as an ER stress transducer (DenBoer et al., 2005; Liang et al., 2006). 
More recently, expression of Luman has been shown to be amongst a group of intracellular 
signalling cascade genes that are up-regulated during liver regeneration and are believed to 
subserve roles in that process (Xu et al., 2009). 
Consistent with the up-regulation in Luman in response to liver tissue regeneration, I 
observe heightened expression following axonal injury in rat primary sensory neurons (Figure 
3.2.4C and 3.3.2). In addition, the higher levels of Luman found in all nervous system tissue 
examined, may be linked to the important secretory function of both neurons and nonneuronal 
glial cells that creates a higher demand for protein production (Jha et al., 2013). In support of this, 
the Luman-like transcription factors are capable of activating the secretory pathway by 
enhancing the expression of secretory pathway genes (Fox et al., 2010), with the drosophila 
equivalent CREB-H and each of the 5 human CREB3 factors also showing linkage to this 
pathway (Barbosa et al., 2013). Finally at a cellular level, I found that there were high levels of 
expression in the region of the hippocampus involved in learning and memory consolidation, a 
highly plastic part of the brain. It is interesting to note that the mRNA expression pattern of one 
of Luman’s target genes HERP (Liang et al., 2006; Truettner et al., 2009), in the hippocampal 
region that I examined, mirrors that which I observed for Luman. As with Luman, HERP 
expression is regulated by cellular stress events. More specifically, in the hippocampus, HERP is 
up-regulated in response to conditions that induce ER stress such as transient ischemia (Truettner 
et al., 2009) and in neurons it is believed to subserve a neuroprotective role by stabilizing ER 
Ca2+ homeostasis and mitochondrial function (Chan et al., 2004). Whether a similar impact on 
Luman expression occurs and whether this is causally linked to the observed HERP responses is 
not known but appears anatomically feasible given the similarities in their expression patterns 
and their ability to both respond to ER cellular stress events. 
 The isolation of a full length rat Luman and its robust expression in the rat nervous 
system provids the tools and rationale for further study of its role in nervous system plasticity 
involving cellular stress responses. 
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4.2 Sensing nerve injury at the axonal ER: Luman serves as a retrograde 
regeneration signal 
Retrograde injury signals help the neuron transition to a regenerative state, assisting the 
neuron in dealing with the increased demand for protein associated with regeneration (Rishal and 
Fainzilber, 2010; Fainzilber et al., 2011; Jung et al., 2012). Despite proteomics and microarray 
analyses revealing that there are ~400 signaling networks connecting to 39 transcription factors 
in the sensory neuron response to axotomy (Michaelevski et al., 2010) and a transcriptome 
analysis identifying Luman as an intra-axonal transcript (Gumy et al., 2011), there is a paucity of 
information on the role(s) that axonally localized and synthesized transcription factors subserve 
beyond neuronal survival as described for CREB and STAT3 (Cox et al., 2008; Ben-Yaakov et 
al., 2012). My results in section 3.2 provide the first insights into the role of the ER-localized 
transcription factor Luman as a critical regulator of intrinsic neurite outgrowth in injured sensory 
neurons. I validated that Luman mRNA localizes to axons (Gumy et al., 2011) and characterized 
the presence of Luman protein in axons. I revealed that Luman is synthesized in, and removed 
from, injured axons via retrograde transport back to the cell body in an importin -dependent, 
but proteasome-independent manner. Finally, I presented evidence supporting a novel role for 
this axonally synthesized transcription factor in specific support of the intrinsic elongating form 
of axonal growth associated with regeneration. 
4.2.1 Luman as an axonal ER-associated transducer of injury stress signals 
My finding that markers of the ER extend the length of the axon is in agreement with 
recent findings by others (Stirling et al., 2014) and provides a mechanism whereby injury at any 
site along this axoplasmic ER may impact ER-associated events. While this could include signals 
derived proximal to the injury site such as the local activation and synthesis of Luman as 
described in this study, I cannot exclude that additional signals propagated along the length of 
the axonal ER may also impact this response (Stirling et al., 2014). 
Luman is an ~60 kDa bZIP transcription factor containing an ER-transmembrane domain 
first that was identified for its potential role in herpes simplex virus reactivation (Lu et al., 1997; 
Raggo et al., 2002). It is expressed by sensory neurons and retained in the ER (Lu and Misra, 
2000), where processing by regulated intramembrane proteolysis releases an ~40 kDa amino 
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terminal fragment (Raggo et al., 2002) containing all identified functional domains, including its 
NLS (Lu et al., 1997; Lu et al., 1998). This provides a mechanism whereby neurons can respond 
to environmental stressors by rapidly activating premade transcription factors. 
Nerve injury activates axonally-localized transcription factors and initiates translation of 
components of their retrograde transport machinery which effects efficient transport back to the 
nucleus via dynein motors [reviewed in (Jung et al., 2012)]. This machinery includes the protein 
importin α found throughout neuronal axons, while the mRNA of another core component, 
importin β, is localized to axons and only translated in response to nerve lesion (Hanz et al., 
2003). Once synthesized, axonal importin  associates with importin  creating a high-affinity 
nuclear localization signal (NLS) binding complex that includes target cargo proteins and that 
traffics retrogradely via the motor protein dynein (Hanz et al., 2003). The repertoire of validated 
axonally synthesized transcription factors shown to traffic in this manner is limited to that of 
STAT3, which mediates neuronal survival following injury (Ben-Yaakov et al., 2012). However, 
the presence of Luman mRNA and protein in axons in this study (Figure 3.2.1), its injury-
induced local synthesis in axons (Figure 3.2.2) and association with importin  in injury-
conditioned but not in the naïve state (Figure 3.2.5) identifies Luman as the second transcription 
factor that can be locally synthesized so that axon autonomous injury/regeneration signals may 
be generated and appropriately relayed back to the nucleus. 
In the naïve state, axonal premade Luman colocalizes with the ER protein calnexin 
consistent with its aforementioned association with the ER and the presence of an ER functional 
equivalent in axons (Merianda et al., 2009). How Luman mRNA is transported into the axon is 
unknown. But it is likely by an interaction of its 3’UTR with a RNA binding protein such as 
ZBP1, which has been shown to be a necessary and rate limiting step in peripheral nerve 
regeneration through its ability to target and translationally repress cargo mRNAs such as -actin 
until needed (Donnelly et al., 2011). 
The rapid appearance of a lower molecular weight form of Luman in the axons at 6 h (the 
earliest time point examined post sciatic nerve injury) is suggestive of activation by regulated 
intramembrane proteolysis. This response in the nerve is transient, consistent with a role as a 
rapid inductive axonal signal. This type of signal transduction requires that the axon-derived 
molecules must be distinguished from similar molecules located in the cell body. The low basal 
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level of cleaved Luman in the cell bodies of uninjured DRGs (Figure 3.2.3C) may allow axon-
derived Luman to substantially impact Luman-dependent transcriptional activities. Its 
disappearance from the nerve coincided with an increased appearance in the nuclei of the injured 
neurons of the corresponding DRG (Figure 3.2.3) along with importin whose axonal 
expression was also increased following axotomy (Figure 3.2.4). Further, the observed 
disappearance of Luman from the injured axons is likely via retrograde transport back to the 
neuronal cell body and not because of degradation, as inhibitors of degradation had no effect on 
its disappearance, while disruption of retrograde transport with colchicine effectively prevented 
it. Notably, these treatments had no discernible effect on the levels of Luman within the axons of 
short term cultures derived from naïve sensory neurons, consistent with the idea that its 
disappearance from axotomized axons requires processes or components not activated or 
synthesized in the naïve state (Figure 3.2.5). Further, even though the naïve neurons are 
axotomized in the process of being dissected, the rapid dissociation process resulting in complete 
removal of axons, and likely does not afford sufficient time for the generation and retrograde 
transport of axonal Luman as an injury signal. 
Injury-associated Luman is likely transported as a cargo protein in the importin complex 
via a NLS/importin interaction, as this could be specifically competed away with an excess of 
NLS peptide (Figure 3.2.5 and 3.2.7). The transient nature of Luman up-regulation in injured 
nerves, its disappearance from the axonal compartment and its subsequent appearance in the 
neuronal nuclei (Figure 3.2.76 and 3.2.8) were consistent with it being an inductive signal in the 
cell body response to the injury. 
4.2.2 Axonal Luman contributes to axonal growth following injury 
The rapid axonal synthesis and subsequent increased nuclear localization of Luman in 
injured adult sensory neurons suggests that it subserves a transcriptional role associated with the 
cell body response to axonal injury. Target genes of this transcriptional regulation are currently 
unknown. However, this form of retrograde signaling does have functional implications with 
respect to promotion of axonal outgrowth in the injured-conditioned sensory neuron (Figures 
3.2.10 and 3.2.12). Previous work has identified retrograde signalling linked to axonal protein 
synthesis as being vital for optimal axon regeneration in the periphery (Gumy et al., 2010; Liu et 
al., 2011). Indeed some speculate that the high capacity of peripheral axons to synthesize 
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proteins in a cell-compartment autonomous way relative to central nervous system axons (Verma 
et al., 2005; Taylor et al., 2009; Vogelaar et al., 2009) may contribute to their differential 
propensities for axonal regeneration. 
I discerned distinct modes of axon growth for neurons associated with the naïve versus 
injury-conditioned states (Figure 3.2.10) in agreement with previous studies (Smith and Skene, 
1997). Localized translation of the axon-targeted -actin and GAP43 mRNAs is critical for these 
distinct modes with roles in axon branching and elongating growth respectively, in sensory 
neurons (Donnelly et al., 2013). Luman siRNA results revealed a novel mode-specific role for 
axonal Luman in injury-conditioned neurons in regulation of only the elongating form of axon 
growth and not branching (Figure 3.2.10). Consistent with the lack of impact on axonal 
branching Luman knockdown did not alter axonal growth patterns observed for neurons that 
were naïve prior to assay (Figure 3.2.10). 
In conclusion, intra-axonal mRNA translation and retrograde transport of the 
transcription factor Luman has been shown to mediate an important form of communication 
between distal axons and the cell bodies in the regulation of axon regrowth in the PNS. 
Elucidating key transcriptional regulators of intrinsic regenerative axonal growth provides novel 
targets for enhancing nerve repair. 
4.3 Activation of the UPR is required for injury-induced neurite 
outgrowth 
Unlike the CNS, which has limited regeneration ability after injury, the PNS axon 
regeneration allows functional recovery after peripheral nerve injury (Huebner and Strittmatter, 
2009). Although the PNS axons are capable of regeneration and form functional innervations, 
several factors, including the injury type, delay before re-innervation, and patient’s age 
determine the degree of functional outcome after repair (Scheib and Hoke, 2013), and the overall 
functional recovery is still disappointing (Johnson et al., 2005). Studying the molecular events 
behind the PNS regeneration will not only help us to find better treatment options for patients 
with PNS injury, but also to understand the differences between PNS and CNS regeneration. 
Complex cellular responses, including calcium influx (Ghosh-Roy et al., 2010), histone 
acetylation (Finelli et al., 2013), axonal protein synthesis (Ben-Yaakov et al., 2012), and 
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retrograde (Ben-Yaakov et al., 2012) and anterograde (Misgeld et al., 2007) axonal transport, 
happen after nerve injury (Mar et al., 2014). In section 3.3, I revealed that the UPR is activated in 
DRGs after sciatic nerve crush injury, and that this activation is required for injury-induced 
neurite outgrowth. 
The UPR is linked to many neurodegenerative disorders. Activation of the UPR has been 
observed in Alzheimer’s disease (Hoozemans et al., 2005), Parkinson’s disease (Hoozemans et 
al., 2007), and multiple sclerosis (Mhaille et al., 2008). The deletion of CHOP and activation of 
XBP1 protect retinal ganglion cells from axon injury-induced cell death (Hu et al., 2012), and 
also promotes Schwann cell survival after injury (Mantuano et al., 2011). The UPR markers that 
I examined in this study were all increased after nerve injury (Figure 3.3.1), indicating that UPR 
is activated in axotomized DRG neurons. 
Luman has similar structure to the UPR-associated transcription factor ATF6 and similar 
DNA-binding specificities to another UPR-associated transcription factor, XBP1, and Luman has 
been previously shown to protect cells against ER stress-induced apoptosis when overexpressed 
(Liang et al., 2006). This suggests that the elevated levels of activated Luman that I observed in 
axotomized sensory neurons may be involved in regulation of the UPR. Consistent with a role 
for Luman in regulation of the UPR in axotomized sensory neurons, I found that the knockdown 
of Luman decreased the level of the UPR induced in the injury-conditioned neurons (Figure 3.3.3) 
as well as the observed axon/neurite outgrowth, but had no effect on the axon/neurite outgrowth 
of naïve neurons in culture (Figure 3.2.10 and 3.2.12), indicating that an increased UPR is a 
requirement for only enhanced, injury-induced axon regeneration. 
To see whether other forms of UPR regulation are implicated in axon/neurite outgrowth, I 
first manipulated the neuronal expression of Luman with Luman siRNA such that it effected 
down-regulation of the UPR and then suppressed the effects with the UPR-inducer tunicamycin 
until the UPR recovered in the Luman knockdown axotomized neurons to a level equivalent to 
that observed in the control axotomized neurons without any impact on the reduced levels of 
Luman and cholesterol effected by Luman down-regulation. Although 2 g/mL tunicamycin 
treatment can increase the transcription of Luman (Liang et al., 2006), I found that the expression 
of Luman was not affected by 2 ng/mL tunicamycin (Figure 3.3.5B). This low concentration of 
tunicamycin was enough to bring the Luman knockdown-induced down-regulation of UPR back 
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to the levels observed in axotomized control neurons, and also partially rescued the axon/neurite 
outgrowth in Luman knockdown neurons (Figure 3.3.5), indicating that a certain level of ER 
stress is beneficial for neurite outgrowth. While this low level of tunicamycin treatment did not 
impact the Luman siRNA down-regulation of expression of Luman at the mRNA level, one 
cannot exclude that there may have been an impact of activation of the low levels of Luman 
protein remaining under these conditions. 
Similar to that observed with cholesterol supplementation, when the UPR was elevated 
above levels normally observed in control axotomized DRG neurons (Figure 3.3.5), it did not 
alter axon/neurite outgrowth, suggesting that the axotomized neurons are capable of coping with 
this extra UPR stress and that additional factors involved in the maximal outgrowth attainable 
were unlikely regulated with the tunicamycin treatment. 
The regulation of cholesterol and the UPR have been shown to be linked (Colgan et al., 
2011), with the UPR being involved in the activation of SREBPs (Kammoun et al., 2009), 
transcription factors that regulate sterol biosynthesis. The activation of SREBPs, ATF6, and 
Luman all requires proteolysis by S1P and S2P (encoded by MBTPS1 and MBTPS2) (Ye et al., 
2000; Raggo et al., 2002). Luman knockdown significantly decreased the expression of genes 
coding for SREBP1 and S2P (Figure 3.3.3) and caused a reduction in cellular cholesterol levels 
(Figure 3.3.4). Cholesterol is an essential component in membrane structure and signal 
transduction. In the CNS, defective cholesterol biosynthesis in mature neurons can be completely 
compensated by cholesterol transfer from astrocytes in vivo (Funfschilling et al., 2012). It 
appears that a similar situation may exist for sensory neurons whereby supplemental cholesterol 
was able to partially compensate for the reduced cholesterol in axotomized Luman knockdown 
neurons by increasing the intrinsic ability of these neurons to extend axons/neurites in vitro 
(Figure 3.2.4). However, cholesterol supplementation did not further increase the growth in 
control siRNA transfected neurons, indicating that normally axotomized DRG neurons are able 
to endogenously synthesize enough cholesterol to support neurite outgrowth when the UPR is 
not being compromised by down-regulation of Luman. The observation that cholesterol and 
tunicamycin treatment only partially rescued neurite outgrowth in Luman knockdown neurons 
suggests the existence of other mechanisms by which Luman regulates neurite outgrowth in 
injury conditioned neurons. 
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Overall, these findings demonstrate for the first time that UPR signaling pathways are 
activated in axotomized DRG neurons, and that induction of the UPR is linked to injury-induced 
axon/neurite outgrowth. The exact function of each UPR pathway in nerve regeneration, and 
whether the up-regulation of UPR promotes the PNS regeneration in vivo still need to be 
investigated. 
4.4 A role for the axonal ER in axon injury 
Neurons are polarized cells with axons and dendrites extending far from the soma. 
Considering the extensive lengths of peripheral axons (the sciatic representing the longest), it is 
not surprising that axons have evolved effective axon-based mechanisms to communicate with 
the soma, and that certain cellular functions are regulated locally. The continuous network of the 
ER that runs longitudinally along the axons (Tsukita and Ishikawa, 1976) suggests that the ER 
plays important roles in regulating axonal homeostasis. 
The ER is a highly conserved organelle in eukaryotic cells. It is responsible for the 
synthesis and folding of membrane and secretory proteins, lipid metabolism, and calcium 
signaling. Studies have also shown that the ER regulates glucose metabolism (Broadwell and 
Cataldo, 1984) and protein synthesis and trafficking [reviewed in (Gonzalez and Couve, 2014)] 
in axons. In sections 3.2 and 3.3, I revealed that the axonal ER functions as an injury signal 
transducer through the ER-associated transcription factor Luman. Indeed, other ER-associated 
proteins, especially the ones regulating the UPR, are involved in axon injury (Hu et al., 2012) 
and neurodegenerative disorders [reviewed in (Doyle et al., 2011)]. 
In section 3.3, I showed that sciatic nerve injury activated the UPR in the DRGs, which 
helped the injured axons to regenerate. Similarly, studies have shown that optic nerve injury 
activates the UPR in the retinal ganglion cells. But instead of promoting regeneration, the 
activated UPR results in neuronal death (Hu et al., 2012). The conflicting outcomes could be 
caused by different responses to injury between the PNS and the CNS, or by the different effects 
of the UPR pathways within these two neuronal subtypes. Although the UPR can be activated by 
axon injury, how the ER senses injury stress remains unclear. The UPR is triggered by the 
accumulation of unfolded proteins which is likely to happen during the regeneration stage when 
protein synthesis is increased. The UPR can also be activated by the treatment of thapsigargin, a 
chemical ER stress inducer which raises the cytosolic Ca2+ concentration. In fact, the Ca2+ influx 
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into the axoplasm is an early event after axon injury, which is required for sealing the axonal 
ends (Yawo and Kuno, 1985), for local protein synthesis and formation of growth cone 
[reviewed in (Mar et al., 2014)]. The increased axonal and somal Ca2+ concentration may perturb 
the Ca2+ homeostasis, therefore inducing the UPR. 
Although increased protein synthesis and Ca2+ concentration occur at both the soma and 
axon levels after axon injury, it is still not known whether the UPR is activated in the injured 
axons as well as in the cell somas. The observations that axonal application of brain-derived 
neurotrophic factor caused XBP1 splicing to happen in the axons (Hayashi et al., 2007), and that 
lysophosphatidic acid treatment increased axonal eIF2 phosphorylation (Vuppalanchi et al., 2012) 
suggest that the UPR can be activated in the axons. But, further studies need to be done to 
determine if axon injury actually induces the UPR within the axon locally. 
4.5 Conclusions 
Research performed in this thesis has greatly extended our understanding of the role of 
Luman and ER stress in the regenerative capacity of adult sensory neurons. Further, it has also 
contributed a number of research tools and insights by which to further dissect these signalling 
pathways in the future. This study isolated the coding sequence of rat Luman and revealed rat 
Luman transcripts in a variety of rat tissues with the highest levels in nervous system tissue. 
Adult sensory axons contain Luman mRNA which is locally translated and then transported to 
the cell body via the importin-mediated retrograde transport system in response to nerve injury. 
Knockdown of Luman impairs the intrinsic ability of injury-conditioned sensory neurons to 
extend the regeneration-associated elongating form of neurites. Finally, the UPR is a major 
mechanism by which Luman regulates injury-induced neurite outgrowth and cholesterol 
biosynthesis may be a major UPR-dependent process that connects axon injury with enhanced 
growth potential in DRG neurons.  
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